Processing 00000000.tx.1: Women and Alzheimers Disease1 Alan J. 

Phrase: "Women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "and"

Phrase: "Alzheimers Disease1 Alan J."
Processing 00000000.tx.2: Lerner Department of Neurology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44120 Address all correspondence and requests for reprint to: Dr. 

Phrase: "Lerner Department of Neurology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0587475:Neurology department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "Case Western Reserve University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0036375:School [Manufactured Object,Organization]

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "Ohio 44120"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028905:Ohio [Geographic Area]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "all correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "requests for reprint"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   790   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.3: Alan J. 

Phrase: "Alan J."
Processing 00000000.tx.4: Lerner, Alzheimer Center, 12200 Fairhill Road, Cleveland, Ohio 44120. 

Phrase: "Lerner,"

Phrase: "Alzheimer Center,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205099:Center [Spatial Concept]

Phrase: "12200 Fairhill Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442650:Road [Manufactured Object]

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "Ohio 44120."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028905:Ohio [Geographic Area]
Processing 00000000.tx.5: E-mail: ajl3{at}po.cwru.edu Alzheimers disease (AD) is the most common neurodegenerative disease associated with aging. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "ajl3{at}po.cwru.edu Alzheimers disease (AD)"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   818   C0002395:Alzheimers disease [Disease or Syndrome]
   795   C0012634:Disease [Disease or Syndrome]
   740 E C1836721:MALS [Finding]
   740 E C3538764:MALS [Gene or Genome]
   740 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "the most common neurodegenerative disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0524851:Neurodegenerative Disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "associated with aging."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0001811:Ageing [Organism Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.6: It can also be classified as a complex polygenetic disease, such as hypertension, coronary artery disease, or schizophrenia, because there are both genetic and environmental factors that result in the phenotypic expression of what is clinically called AD. 

Phrase: "It"

Phrase: "can"

Phrase: "also"

Phrase: "be"

Phrase: "classified as a complex polygenetic disease,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0008902:Classified [Classification]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0439855:Complex [Qualitative Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "such as hypertension,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020538:Hypertension [Disease or Syndrome]
  1000   C1963138:Hypertension [Finding]

Phrase: "coronary artery disease,"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0010054:coronary artery disease [Disease or Syndrome]
  1000   C0010068:Coronary (artery) disease [Disease or Syndrome]
           Coronary Disease
  1000   C1956346:Coronary Artery Disease [Disease or Syndrome]
   901   C0205042:Coronary artery [Body Part, Organ, or Organ Component]
   901   C0852949:artery disease [Disease or Syndrome]
   901   C1269008:Coronary artery [Body Part, Organ, or Organ Component]
   827   C0003842:Artery [Body Part, Organ, or Organ Component]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0018787:coronary [Body Part, Organ, or Organ Component]
   827   C0226004:artery [Body System]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C0221464:Arterial [Spatial Concept]

Phrase: "or"

Phrase: "schizophrenia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036341:Schizophrenia [Mental or Behavioral Dysfunction]

Phrase: "because"

Phrase: "there"

Phrase: "are"

Phrase: "both genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
  1000   C0017296:GENETIC [Therapeutic or Preventive Procedure]
  1000   C0314603:Genetic [Functional Concept]
   944 E C0005615:Birth [Organism Function]
   944 E C0035150:Reproduction [Organism Function]
   944 E C0079946:origin [Classification]
   944 E C0439659:Origin [Temporal Concept]
   944 E C1550512:origin [Intellectual Product]
   944 E C1550722:birth [Idea or Concept]
   944 E C3245487:birth [Intellectual Product]
   916 E C0454729:Natal [Geographic Area]
   916 E C0559522:Genital [Body System]
   916 E C1546649:Genital [Intellectual Product]
   916 E C1550642:Genital [Body Substance]
   907 E C0205313:Original [Idea or Concept]
   907 E C2347409:Original [Occupational Activity]
   888 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "environmental factors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1516998:Environmental Factors [Functional Concept]
   983 E C0686732:Environmental Factor [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "result in the phenotypic expression of what"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0031437:Phenotypic expression [Organism Attribute]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "is"

Phrase: "clinically called AD."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0002395:Alzheimers disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.7: Due to the demographic shifts and remarkable medical advances of the last century, aging populations are now the fastest growing portions of the population, and women constitute a majority of this population due to their increased life expectancy relative to males. 

Phrase: "Due to the demographic shifts"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0333051:shifts [Functional Concept]
   827 E C2347509:Shift [Phenomenon or Process]

Phrase: "and"

Phrase: "remarkable medical advances of the last century,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0725066:Advance [Medical Device]

Phrase: "aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "are"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "the fastest growing portions of the population,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0449719:Portion [Spatial Concept]

Phrase: "and"

Phrase: "women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "constitute"

Phrase: "a majority of this population"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "due to their increased life expectancy"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0023671:Life Expectancy [Group Attribute]
   827   C0376558:Life [Idea or Concept]
   827   C0679138:Expectancy [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: "relative to males."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.8: Thus, women would appear to be at special risk for AD, although this review will also focus on gender differences in disease expression and opportunities for treatment using estrogen replacement therapy (ERT). 

Phrase: "Thus,"

Phrase: "women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "would"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be at special risk"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035647:Risk [Qualitative Concept]
   770   C0205555:Special [Qualitative Concept]
   770   C2987476:Be [Conceptual Entity]

Phrase: "for AD,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "although"

Phrase: "this review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "will"

Phrase: "also focus on gender differences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205234:Focus [Spatial Concept]
   760   C1285542:focus [Functional Concept]

Phrase: "in disease expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "opportunities for treatment"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "estrogen replacement therapy (ERT)."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0014935:Estrogen Replacement Therapy [Therapeutic or Preventive Procedure]
           Estrogen Replacement
   913   C0279494:estrogen therapy [Therapeutic or Preventive Procedure]
   901   C0086258:Estrogen Replacement [Therapeutic or Preventive Procedure]
   901   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1363945:Therapy [Finding]
   827   C1555302:Replacement [Idea or Concept]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.9: Alzheimers disease was first described by Alois Alzheimer in 1906, based on a single case of a 51-yr-old woman who developed severe behavioral disturbances, aphasia, and memory loss. 

Phrase: "Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "described by Alois Alzheimer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1552738:described [Idea or Concept]

Phrase: "in 1906,"

Phrase: "based on a single case of a 51-yr-old woman"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   738   C0037179:Single [Population Group]
   738   C0043210:Woman [Population Group]
   738   C0087136:single [Finding]
   738   C0205171:Single [Quantitative Concept]
   738   C0439234:yr [Temporal Concept]
   738   C0580836:Old [Temporal Concept]
   738   C0868928:Case [Functional Concept]
   738   C1527178:Based [Functional Concept]
   738   C1705938:Based [Idea or Concept]
   738   C1706255:CASE [Medical Device]
   738   C1706256:Case [Conceptual Entity]
   704 E C0002055:base [Inorganic Chemical]
   704 E C0178499:Base [Chemical Viewed Functionally]
   704 E C1880279:Base [Biomedical or Dental Material]

Phrase: "who"

Phrase: "developed"

Phrase: "severe behavioral disturbances,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1822046:Behavioral disturbances [Finding]
   793   C2699787:Disturbance [Qualitative Concept]

Phrase: "aphasia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003537:Aphasia [Mental or Behavioral Dysfunction]
   928 E C0234461:Aphasic [Sign or Symptom]

Phrase: "and"

Phrase: "memory loss."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002622:Memory loss [Mental or Behavioral Dysfunction]
  1000   C0751295:Memory Loss [Sign or Symptom]
   861   C1517945:Loss [Quantitative Concept]
Processing 00000000.tx.10: Alzheimer followed the patient for several years and described the classic neuropathological findings of intracellular neurofibrillary tangles and neuritic amyloid plaques in her brain postmortem. 

Phrase: "Alzheimer"

Phrase: "followed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the patient for several years"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:*^patient [Patient or Disabled Group]

Phrase: "and"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "the classic neuropathological findings of intracellular neurofibrillary tangles"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   744   C2607943:findings [Functional Concept]
   744   C2926606:Findings [Clinical Attribute]
   744   C3539655:Findings [Intellectual Product]
   711 E C0037088:Finding [Sign or Symptom]
   711 E C0243095:Finding [Finding]
   711 E C2825141:Finding [Finding]

Phrase: "and"

Phrase: "neuritic amyloid plaques in her brain postmortem."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   778   C0333463:amyloid plaques [Acquired Abnormality]
           Neuritic Plaques
           plaques
   778   C2936349:Plaques, Amyloid [Acquired Abnormality]
   714 E C0011389:Plaque [Disease or Syndrome]
   714 E C0332461:Plaque [Finding]
Processing 00000000.tx.11: Emil Kraeplin proposed the disease eponym several years after his initial description. 

Phrase: "Emil Kraeplin"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "the disease eponym several years after his initial description."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0439234:years [Temporal Concept]
   708 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.12: Remarkably, Alzheimers original notes, and the original neuropathological specimens have been recovered within the past 2 yr, confirming that the patient did indeed have AD by modern diagnostic criteria (1, 2). 

Phrase: "Remarkably,"

Phrase: "Alzheimers original notes,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1317574:Notes [Intellectual Product]
   793 E C1316572:Note [Clinical Attribute]
   793 E C1369612:Note [Clinical Attribute]

Phrase: "and"

Phrase: "the original neuropathological specimens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0370003:specimens [Substance]
   793 E C2347026:Specimen [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "recovered within the past 2 yr,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0439234:yr [Temporal Concept]
   753   C0521108:recovered [Qualitative Concept]
   753   C1444637:Past [Temporal Concept]
   719 E C2004454:recover [Organism Function]

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "did"

Phrase: "indeed"

Phrase: "have"

Phrase: "AD by modern diagnostic criteria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0002395:Alzheimers disease [Disease or Syndrome]
   753   C0012634:Disease [Disease or Syndrome]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.13: Epidemiology Although AD was long believed to be a rare disease, awareness of AD prevalence was highlighted in the late 1960s and 1970s by Blessed and colleagues (3) and Katzman (4). 

Phrase: "Epidemiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014507:Epidemiology [Biomedical Occupation or Discipline]
  1000   C0014508:epidemiology [Functional Concept]
  1000   C0699910:epidemiology [Health Care Activity]

Phrase: "Although"

Phrase: "AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "long"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205166:Long [Qualitative Concept]
  1000   C1706317:Long [Qualitative Concept]

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a rare disease,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0678236:Rare Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "awareness of AD prevalence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0004448:Awareness [Mental Process]

Phrase: "was"

Phrase: "highlighted in the late 1960s"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205087:Late [Temporal Concept]
   760   C0681755:1960s [Temporal Concept]

Phrase: "and"

Phrase: "1970s by Blessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0681756:1970s [Temporal Concept]

Phrase: "and"

Phrase: "colleagues"

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "Katzman"

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.14: Present epidemiological data suggest that dementia, defined as the clinical state of acquired cognitive loss in multiple domains, affects about 57% of individuals over age 65 yr. 

Phrase: "Present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "epidemiological data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that dementia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "defined as the clinical state of acquired cognitive loss"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   742   C0205210:Clinical [Qualitative Concept]
   742   C0439661:Acquired [Temporal Concept]
   742   C1301808:State [Geographic Area]
   742   C1442792:State [Functional Concept]
   742   C1516691:Cognitive [Functional Concept]
   742   C1517945:Loss [Quantitative Concept]
   742   C1704788:Defined [Conceptual Entity]
   742   C3148680:State [Geographic Area]
   742   C3245488:acquired [Intellectual Product]
   742   C3539106:Defined [Intellectual Product]

Phrase: "in multiple domains,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "affects about 57% of individuals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0001721:Affect [Mental Process]
   726   C0027361:Individual [Population Group]
   726   C0237401:Individual [Human]

Phrase: "over age 65 yr."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439234:yr [Temporal Concept]
Processing 00000000.tx.15: In the East Boston study of community-dwelling elderly, by age 85 yr up to 47% of individuals will suffer dementia (5). 

Phrase: "In the East Boston study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: "of community-dwelling elderly,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001792:Elderly [Population Group]
   827   C1999167:elderly [Population Group]

Phrase: "by age 85 yr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439234:yr [Temporal Concept]

Phrase: "up to 47%"

Phrase: "of individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "will"

Phrase: "suffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683278:suffer [Mental or Behavioral Dysfunction]

Phrase: "dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.16: The vast majority of these cases will have AD. 

Phrase: "The vast majority of these cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680220:majority [Social Behavior]

Phrase: "will"

Phrase: "have"

Phrase: "AD."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.17: Translated into population statistics, these numbers imply a current U.S. prevalence of about 4 million cases. 

Phrase: "Translated into population statistics,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0032685:Population Statistics [Quantitative Concept]
   770   C0032659:Population [Quantitative Concept]
   770   C0038215:Statistics [Occupation or Discipline]
   770   C0040710:translated [Occupational Activity]
   770   C0600673:Statistics [Intellectual Product]
   770   C1257890:Population [Population Group]
   737 E C2348149:Statistic [Quantitative Concept]
   737 E C2828391:Statistic [Quantitative Concept]

Phrase: "these numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "imply"

Phrase: "a current U.S. prevalence of about 4 million cases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0033105:Prevalence [Quantitative Concept]
   739   C0220900:prevalence [Quantitative Concept]
Processing 00000000.tx.18: This has been estimated to cost between 70100 billion dollars/yr, much of it due to the need for long term care facilities. 

Phrase: "This"

Phrase: "has"

Phrase: "been"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cost between 70100 billion dollars/yr,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0010186:Cost [Quantitative Concept]
   753   C0220812:cost [Quantitative Concept]
   753   C0439234:yr [Temporal Concept]
   753   C0562019:dollars [Quantitative Concept]

Phrase: "much of it"

Phrase: "due to the need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "for long term care facilities."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   966   C1708733:Long-Term Care Facility [Health Care Related Organization]
   923   C0023977:long-term care [Health Care Activity]
   923   C1547194:Long Term Care [Health Care Related Organization]
   923   C1552238:Long-Term Care [Professional or Occupational Group]
   861   C0443252:Long-term [Temporal Concept]
   812   C0205166:Long [Qualitative Concept]
   812   C1515273:Term [Temporal Concept]
   812   C1705313:Term [Idea or Concept]
   812   C1706317:Long [Qualitative Concept]
   812   C1947933:Care [Activity]
   812   C2826302:TERM [Intellectual Product]
   779   C1547538:Facility [Idea or Concept]
Processing 00000000.tx.19: With women over 65 yr of age outnumbering men (20 million women vs. 13.9 million men in the U.S.), and with an American women who reaches age 65 yr having an average life expectancy of 19 yr (15.5 yr for men), women appear to be at particular risk for AD. 

Phrase: "With women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "over 65 yr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439234:yr [Temporal Concept]

Phrase: "of age outnumbering men (20 million women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0043210:Women [Population Group]

Phrase: "vs. 13.9 million men in the U.S."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   742   C0025266:Men [Population Group]
   708 E C0024554:MAN [Finding]
   708 E C0086418:Man [Human]

Phrase: ")"

Phrase: ","

Phrase: "and with an American women"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0043210:Women [Population Group]
   760   C0596070:American [Population Group]
   760   C1515981:And [Idea or Concept]

Phrase: "who"

Phrase: "reaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0596012:Reaches [Finding]
  1000   C2584321:Reach [Organism Function]

Phrase: "age 65 yr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439234:yr [Temporal Concept]

Phrase: "having"

Phrase: "an average life expectancy of 19 yr (15.5 yr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0023671:Life Expectancy [Group Attribute]
   739   C0376558:Life [Idea or Concept]
   739   C0679138:Expectancy [Idea or Concept]

Phrase: "for men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]

Phrase: ")"

Phrase: ","

Phrase: "women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be at particular risk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035647:Risk [Qualitative Concept]
   770   C2987476:Be [Conceptual Entity]

Phrase: "for AD."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.20: Meta-analysis of population prevalence studies found no sex difference in overall dementia prevalence by gender, but showed that AD rates tend to be higher in females, and vascular dementia tends to be more common in males. 

Phrase: "Meta-analysis of population prevalence studies"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0282458:Meta-Analysis [Intellectual Product]
   790   C0920317:Meta-Analysis [Research Activity]
   783   C1514228:Population Analysis [Research Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1042496:Meta [Eukaryote]
   753   C1524024:analysis [Functional Concept]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no sex difference in overall dementia prevalence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0036866:Sex Difference [Organism Attribute]
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "by gender,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "but"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that AD rates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0026538:disease rates [Quantitative Concept]
   793   C0871208:Rate [Activity]
   793   C1521828:Rate [Quantitative Concept]
   734   C0002395:Alzheimers disease [Disease or Syndrome]

Phrase: "tend"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "higher in females,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "and"

Phrase: "vascular dementia"
Meta Candidates (Total=14; Excluded=8; Pruned=0; Remaining=6)
  1000   C0011269:Dementia, Vascular [Disease or Syndrome]
   861   C0005847:vascular [Body Part, Organ, or Organ Component]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   861   C1558950:VASCULAR [Finding]
   861   C1801960:Vascular [Qualitative Concept]
   805 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   805 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C0005767:Blood [Tissue]
   761 E C0005768:blood [Body Substance]
   761 E C0229664:Blood [Body Substance]
   761 E C0392895:Bloods [Population Group]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
   745 E C0333275:Bloody [Qualitative Concept]

Phrase: "tends"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "more common in males."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1865401:More common in males [Finding]
   770   C0205214:Common [Quantitative Concept]
   770   C1522138:Common [Functional Concept]
   770   C3245511:common [Intellectual Product]
Processing 00000000.tx.21: A meta-analysis of incidence studies (6) across different nationalities showed little difference in overall gender-specific incidence. 

Phrase: "A meta-analysis of incidence studies"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0282458:Meta-Analysis [Intellectual Product]
   790   C0920317:Meta-Analysis [Research Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1042496:Meta [Eukaryote]
   753   C1524024:analysis [Functional Concept]

Phrase: "(6"

Phrase: ")"

Phrase: "across different nationalities"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027473:Nationalities [Group Attribute]
   777 E C3245503:national [Intellectual Product]
   755 E C1555720:Nation [Organization]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "little difference in overall gender-specific incidence."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0036866:gender difference [Organism Attribute]
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.22: AD incidence for women showed a steeper age-incidence curve, indicating a higher incidence at older ages. 

Phrase: "AD incidence for women"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a steeper age-incidence curve,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205134:Curve [Spatial Concept]

Phrase: "indicating"

Phrase: "a higher incidence at older ages."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0021149:Incidence [Quantitative Concept]
   753   C0220856:incidence [Functional Concept]
Processing 00000000.tx.23: East Asian countries had lower AD incidence than Europe or the U.S., but their incidence curve steepens with age, which may reflect environmental or genetic differences contributing to AD risk. 

Phrase: "East Asian countries"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C0015631:East Asian country [Geographic Area]
   901   C0454705:asian countries [Geographic Area]
   827   C0454664:Countries [Geographic Area]

Phrase: "had"

Phrase: "lower AD incidence than Europe"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0021149:Incidence [Quantitative Concept]
   753   C0220856:incidence [Functional Concept]

Phrase: "or"

Phrase: "the U.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:U S [Geographic Area]

Phrase: "but"

Phrase: "their incidence curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205134:Curve [Spatial Concept]

Phrase: "steepens with age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001779:Age [Organism Attribute]

Phrase: "which"

Phrase: "may"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "environmental"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014406:Environmental [Spatial Concept]

Phrase: "or"

Phrase: "genetic differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "contributing to AD risk."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0002395:Alzheimers disease [Disease or Syndrome]
   806   C1281905:disease risk [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0035647:Risk [Qualitative Concept]
   760   C1880177:Contributing [Activity]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.24: The issue of AD in the oldest old (over age 85 yr) has also been investigated, with particular reference to whether AD is an inevitable part of aging (7). 

Phrase: "The issue of AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033213:Issue [Finding]
   760   C1706387:Issue [Intellectual Product]

Phrase: "in the oldest old ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001795:Oldest Old [Age Group]

Phrase: "over age 85 yr)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439234:yr [Temporal Concept]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: ","

Phrase: "with particular reference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514811:Reference [Idea or Concept]
   861   C1706462:Reference [Conceptual Entity]

Phrase: "to"

Phrase: "whether"

Phrase: "AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "an inevitable part of aging"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1292711:Part of [Spatial Concept]
   760   C0449719:Part [Spatial Concept]
   760   C1709471:Part [Quantitative Concept]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.25: Genetic marker studies involving apolipoprotein E (Apo E), whose e4 allele is a well established disease risk modifier (see below), have also suggested that the vast majority of Apo E e4 carriers will be demented by age 120 yr, although the incidence curves also become flatter after age 90 yr. 

Phrase: "Genetic marker studies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   896   C2827447:Genetic Study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0017393:Marker, Genetic [Genetic Function]
   734   C0600223:genetic marker [Laboratory Procedure]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "apolipoprotein E (Apo E),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "whose e4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "a well established disease risk modifier"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0205349:Modifier [Qualitative Concept]
   804   C1514623:Modifier [Conceptual Entity]
   804   C1516451:Modifier [Chemical Viewed Functionally]
   804   C3542952:Modifier [Intellectual Product]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")"

Phrase: ","

Phrase: "have"

Phrase: "also"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the vast majority of Apo E e4 carriers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0680220:majority [Social Behavior]

Phrase: "will"

Phrase: "be"

Phrase: "demented by age 120 yr,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0001779:Age [Organism Attribute]
   760   C0439234:yr [Temporal Concept]
   760   C0860630:demented [Mental or Behavioral Dysfunction]

Phrase: "although"

Phrase: "the incidence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0021149:Incidence [Quantitative Concept]
  1000   C0220856:incidence [Functional Concept]
   928 E C1551358:incident [Idea or Concept]

Phrase: "curves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205134:Curve [Spatial Concept]

Phrase: "also"

Phrase: "become"

Phrase: "flatter after age 90 yr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0205324:Flat [Spatial Concept]
   726   C0457933:Flat [Manufactured Object]
Processing 00000000.tx.26: Jorm and Jolly (6) found no evidence of incidence curve flattening after age 90 yr. 

Phrase: "Jorm"

Phrase: "and"

Phrase: "Jolly (6"

Phrase: ")"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no evidence of incidence curve flattening"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "after age 90 yr."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439234:yr [Temporal Concept]
Processing 00000000.tx.27: These studies are beginning to provide scientific basis for anecdotes suggesting that great longevity need not be accompanied by inevitable deterioration of cognition. 

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "beginning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Beginning [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "scientific basis for anecdotes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1527178:Basis [Functional Concept]
   770   C1874451:Basis [Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that great longevity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023980:Longevity [Temporal Concept]

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "accompanied by inevitable deterioration of cognition."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0009240:Cognition [Mental Process]
   753   C0868945:Deterioration [Phenomenon or Process]
Processing 00000000.tx.28: Studies in developing nations have produced interesting results regarding gender issues and environmental and genetic risks for AD. 

Phrase: "Studies in developing nations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "produced"

Phrase: "interesting results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "regarding"

Phrase: "gender issues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0282206:Gender Issues [Qualitative Concept]
   827   C0033213:Issue [Finding]
   827   C1706387:Issue [Intellectual Product]

Phrase: "and"

Phrase: "environmental"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014406:Environmental [Spatial Concept]

Phrase: "and"

Phrase: "genetic risks for AD."
Meta Candidates (Total=15; Excluded=9; Pruned=0; Remaining=6)
   797   C0019247:Genetic disease [Disease or Syndrome]
   797   C1281905:disease risks [Finding]
   773   C1517512:Genetic Risk [Quantitative Concept]
   760   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   760   C0035647:Risks [Qualitative Concept]
   760   C0314603:Genetic [Functional Concept]
   756 E C2316203:Genetic diseases [Finding]
   756 E C2924406:Genetic diseases [Laboratory Procedure]
   704 E C0005615:Birth [Organism Function]
   704 E C0035150:Reproduction [Organism Function]
   704 E C0079946:origin [Classification]
   704 E C0439659:Origin [Temporal Concept]
   704 E C1550512:origin [Intellectual Product]
   704 E C1550722:birth [Idea or Concept]
   704 E C3245487:birth [Intellectual Product]
Processing 00000000.tx.29: In rural elderly in Northern India, Chandra et al. found no gender or literacy association, although prevalence increased with age (8). 

Phrase: "In rural elderly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001792:Elderly [Population Group]
   861   C1999167:elderly [Population Group]

Phrase: "in Northern India,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0021201:India [Geographic Area]
   861   C2700456:India [Fish]
   789 E C1524069:Indian [Population Group]

Phrase: "Chandra et al."

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no gender"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "or"

Phrase: "literacy association,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "although"

Phrase: "prevalence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033105:Prevalence [Quantitative Concept]
  1000   C0220900:prevalence [Quantitative Concept]

Phrase: "increased with age (8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001779:Age [Organism Attribute]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]

Phrase: ")."
Processing 00000000.tx.30: A low prevalence and incidence were been found in Ibadan, Nigeria compared to that in African-Americans in Indianapolis, IN (8.24% in Indianapolis vs. 2.3% in Ibadan) (9). 

Phrase: "A low prevalence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1518029:Low Prevalence [Quantitative Concept]
   861   C0033105:Prevalence [Quantitative Concept]
   861   C0220900:prevalence [Quantitative Concept]

Phrase: "and"

Phrase: "incidence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0021149:Incidence [Quantitative Concept]
  1000   C0220856:incidence [Functional Concept]
   928 E C1551358:incident [Idea or Concept]

Phrase: "were"

Phrase: "been"

Phrase: "found in Ibadan,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "Nigeria"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0028075:Nigeria [Geographic Area]
   928 E C1556089:Nigerian [Population Group]

Phrase: "compared to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "in African-Americans"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085756:African Americans [Population Group]
   861   C0027567:African [Population Group]
   861   C0596070:americans [Population Group]

Phrase: "in Indianapolis,"

Phrase: "IN (8.24% in Indianapolis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:In [Quantitative Concept]
   760   C0332285:In [Spatial Concept]

Phrase: "vs. 2.3% in Ibadan"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704629:VS [Idea or Concept]
   760   C1704752:VS [Intellectual Product]

Phrase: ")"

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.31: A cross-cultural study of Japanese-American men living in Hawaii found that height correlated negatively with dementia prevalence, suggesting that early life dietary adequacy may play a role in late-onset brain disorders (10). 

Phrase: "A cross-cultural study of Japanese-American men"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C0087107:cross-cultural study [Research Activity]
   744   C0557651:Study [Manufactured Object]
   744   C2603343:Study [Research Activity]

Phrase: "living in Hawaii"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0018619:Hawaii [Geographic Area]
   790   C0376558:Living [Idea or Concept]
   756 E C1548795:Live [Qualitative Concept]
   756 E C1634625:% live [Qualitative Concept]
   756 E C2982691:Live [Activity]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that height"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0489786:Height [Organism Attribute]
   928 E C0205250:High [Qualitative Concept]
   928 E C1299351:High [Qualitative Concept]
   928 E C1522410:Highest [Qualitative Concept]
   928 E C2700149:HIGH [Intellectual Product]

Phrase: "correlated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707520:Correlated [Qualitative Concept]

Phrase: "negatively with dementia prevalence,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0033105:Prevalence [Quantitative Concept]
   770   C0220900:prevalence [Quantitative Concept]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that early life dietary adequacy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   741   C0205410:Adequate [Qualitative Concept]
   741   C0205411:Adequate [Qualitative Concept]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in late-onset brain disorders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.32: Studies are currently underway in geographically or genetically isolated populations, such as Central Kenya, Brazil, and Israeli Arabs, and many others that may help determine whether genetic or environmental factors, such as toxins, literacy and education, physical activity, nicotine exposure, or other variables are important in determining AD development (11, 12, 13). 

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "currently underway in geographically"

Phrase: "or"

Phrase: "genetically isolated populations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "such as Central Kenya,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0022558:Kenya [Geographic Area]
   789 E C0337839:kenyan [Population Group]

Phrase: "Brazil,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006137:Brazil [Geographic Area]

Phrase: "and"

Phrase: "Israeli Arabs,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0282540:Arabs [Population Group]
   861   C1947963:arabs [Eukaryote]
   827 E C1561448:Arab [Population Group]

Phrase: "and"

Phrase: "many others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "that"

Phrase: "may"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
  1000   C0017296:GENETIC [Therapeutic or Preventive Procedure]
  1000   C0314603:Genetic [Functional Concept]
   944 E C0005615:Birth [Organism Function]
   944 E C0035150:Reproduction [Organism Function]
   944 E C0079946:origin [Classification]
   944 E C0439659:Origin [Temporal Concept]
   944 E C1550512:origin [Intellectual Product]
   944 E C1550722:birth [Idea or Concept]
   944 E C3245487:birth [Intellectual Product]
   916 E C0454729:Natal [Geographic Area]
   916 E C0559522:Genital [Body System]
   916 E C1546649:Genital [Intellectual Product]
   916 E C1550642:Genital [Body Substance]
   907 E C0205313:Original [Idea or Concept]
   907 E C2347409:Original [Occupational Activity]
   888 E C0598240:originality [Mental Process]

Phrase: "or"

Phrase: "environmental factors,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1516998:Environmental Factors [Functional Concept]
   983 E C0686732:Environmental Factor [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "such as toxins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040549:Toxins [Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "literacy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0023864:Literacy [Functional Concept]
   928 E C0682193:literate [Finding]

Phrase: "and"

Phrase: "education,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0013621:Education [Educational Activity]
  1000   C0013622:education [Classification]
  1000   C0013658:Education, NOS [Finding]
  1000   C0039401:Education [Educational Activity]
   928 E C1555905:Educational [Intellectual Product]

Phrase: "physical activity,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0026606:Physical activity [Daily or Recreational Activity]
   861   C0031809:Physical [Health Care Activity]
   861   C0205177:Activity [Functional Concept]
   861   C0205485:Physical [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1509143:Physical [Finding]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "nicotine exposure,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0240502:NICOTINE EXPOSURE [Finding]
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]

Phrase: "or"

Phrase: "other variables"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439828:variables [Qualitative Concept]

Phrase: "are"

Phrase: "important in determining AD development"

Phrase: "(11,"

Phrase: "12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.33: One methodological issue in all of these studies, especially in developing nations, is the censuring effect of competing sources of mortality, which would tend to favor AD expression in women. 

Phrase: "One methodological issue in all of these studies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0033213:Issue [Finding]
   744   C1706387:Issue [Intellectual Product]

Phrase: "especially in developing nations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0011750:Developing Nations [Qualitative Concept]
   737   C1555720:Nation [Organization]

Phrase: "is"

Phrase: "the censuring effect of competing sources of mortality,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "which"

Phrase: "would"

Phrase: "tend"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "AD expression in women."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.34: More subtly, the life experiences of women, their educational and vocational opportunities, their access to health care, medications, and disease exposures may affect their risks of AD in ways that current research is only beginning to comprehend. 

Phrase: "More subtly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "the life"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0376558:Life [Idea or Concept]
   916 E C0595998:lives [Finding]

Phrase: "experiences of women,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043210:Women [Population Group]
   790   C0237607:experience [Mental Process]
   790   C0596545:Experience [Mental Process]

Phrase: "their educational"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C1555905:Educational [Intellectual Product]
   928 E C0013621:Education [Educational Activity]
   928 E C0013622:education [Classification]
   928 E C0013658:Education, NOS [Finding]
   928 E C0039401:Education [Educational Activity]

Phrase: "and"

Phrase: "vocational opportunities,"

Phrase: "their access to health care,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   926   C0018748:Access to Health Care [Qualitative Concept]
           Access to Care
           Health Care Access
   760   C0444454:Access [Spatial Concept]
   760   C1554204:access [Idea or Concept]

Phrase: "medications,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0013227:Medications [Pharmacologic Substance]
  1000   C0802604:Medications [Clinical Attribute]
  1000   C2598133:Medications [Clinical Attribute]
   966 E C3244316:medication [Functional Concept]

Phrase: "and"

Phrase: "disease exposures"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   941   C0848543:diseases exposure [Finding]
   861   C0274281:exposures [Injury or Poisoning]
   861   C0728853:exposures [Phenomenon or Process]
   827 E C0332157:Exposure [Clinical Attribute]

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "their risks of AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risks [Finding]
   760   C0035647:Risks [Qualitative Concept]

Phrase: "in ways"

Phrase: "that current research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "is"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "beginning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Beginning [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "comprehend."
Processing 00000000.tx.35: Genetic risk factors Beginning with the observation that individuals with Downs syndrome almost universally develop neuropathological and frequently clinical evidence of AD by age 35 yr and the discovery of familial forms of AD, interest in the genetic risk factors for AD has been an active field of investigation. 

Phrase: "Genetic risk factors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0814299:genetic risk factors [Qualitative Concept]
   901   C0035648:risk factors [Quantitative Concept]
   901   C1553898:risk factors [Idea or Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
   734   C1517512:Genetic Risk [Quantitative Concept]

Phrase: "Beginning with the observation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0302523:Observation [Research Activity]
   770   C0439659:Beginning [Temporal Concept]
   770   C0700325:observation [Health Care Activity]
   770   C1964257:Observation [Diagnostic Procedure]

Phrase: "that individuals with Downs syndrome almost universally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0027361:Individual [Population Group]
   714   C0237401:Individual [Human]

Phrase: "develop"

Phrase: "neuropathological"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   928   C1540677:neuropathology [Pathologic Function]
   928   C1555824:Neuropathology [Intellectual Product]

Phrase: "and"

Phrase: "frequently clinical evidence of AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "by age 35 yr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439234:yr [Temporal Concept]

Phrase: "and"

Phrase: "the discovery of familial forms of AD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880355:Discovery [Activity]

Phrase: "interest in the genetic risk factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0543488:Interest [Mental Process]

Phrase: "for AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "an active field of investigation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   760   C1521738:Field [Conceptual Entity]
   760   C2346620:Field [Conceptual Entity]
   760   C2349184:Field [Conceptual Entity]
   760   C3539073:FIELD [Spatial Concept]
Processing 00000000.tx.36: To date, three AD genes have been isolated: mutations of the amyloid precursor protein on chromosome 21 (21q21), of presenilin-1 on chromosome 14 (14q24.3), and of presenilin-2 on chromosome 1 (1q31.42). 

Phrase: "To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "three AD genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   816   C1416989:MAL gene [Gene or Genome]
   812   C0017337:Genes [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: ":"

Phrase: "mutations of the amyloid precursor protein"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "on chromosome 21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008664:Chromosome 21 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "(21q21"

Phrase: ")"

Phrase: ","

Phrase: "of presenilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "on chromosome 14"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008656:Chromosome 14 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "(14q24.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1520594:14q24.3 [Cell Component]
   861   C1520591:14q24 [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "and of presenilin-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1418986:PRESENILIN 2 [Gene or Genome]
   770   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   770   C1515981:And [Idea or Concept]

Phrase: "on chromosome 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008651:Chromosome 1 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "(1q31.42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521005:1q31 [Cell Component]

Phrase: ")."
Processing 00000000.tx.37: These rare mutations have generated new insights into the molecular biology of AD in terms of amyloid processing and differential processing of the APP, but are clinically very rare. 

Phrase: "These rare mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "generated new insights into the molecular biology of AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0233820:insights [Mental Process]

Phrase: "in terms of amyloid processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "differential processing of the APP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709694:Processing [Activity]

Phrase: "but"

Phrase: "are"

Phrase: "clinically very rare."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1855575:Very rare [Finding]
   827   C0521114:Rare [Temporal Concept]
   827   C0522498:Rare [Qualitative Concept]
   827   C1514917:RARE [Gene or Genome]
Processing 00000000.tx.38: The most important AD gene identified to date is the disease risk modifier, Apo E (19q13.2), particularly the presence of the e4 allele (14, 15). 

Phrase: "The most important AD gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1416989:MAL gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]

Phrase: "identified to date"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0011008:Date [Temporal Concept]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   790   C2348077:Date [Food]

Phrase: "is"

Phrase: "the disease risk modifier,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205349:Modifier [Qualitative Concept]
   827   C1514623:Modifier [Conceptual Entity]
   827   C1516451:Modifier [Chemical Viewed Functionally]
   827   C3542952:Modifier [Intellectual Product]
   734   C1281905:disease risk [Finding]

Phrase: "Apo E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(19q13.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1520860:19q13.2 [Cell Component]
   861   C1520855:19q13 [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "particularly"

Phrase: "the presence of the e4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(14,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.39: Apo E e4 status has been associated with both late-onset and early-onset familial forms of AD, as well as being a general risk factor for AD. 

Phrase: "Apo E e4 status"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0449438:Status [Qualitative Concept]
   708   C0052201:Apolipoprotein E4 [Amino Acid, Peptide, or Protein]

Phrase: "has"

Phrase: "been"

Phrase: "associated with both late-onset"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0205087:Late [Temporal Concept]
   760   C0332162:Onset [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "early-onset familial forms of AD,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   993   C2931257:Early-onset familial form of Alzheimer disease [Disease or Syndrome]
   762   C1832428:Familial form [Finding]
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   721   C0338445:Familial Alzheimer's disease of early onset [Disease or Syndrome]
   714 E C1522492:Form [Functional Concept]

Phrase: "as well as"

Phrase: "being"

Phrase: "a general risk factor for AD."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   804   C0850664:disease risk factor [Finding]
   778   C0035648:Risk factor [Quantitative Concept]
   774   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   774   C0679238:disease factor [Functional Concept]
   774   C0960756:factor A [Organic Chemical]
   774   C1281905:disease risk [Finding]
   748   C0035647:Risk [Qualitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.40: Individuals carrying at least one e4 allele have between a 2540% lifetime chance of developing AD. 

Phrase: "Individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "carrying at least one e4 allele"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0002085:Allele [Gene or Genome]
   753   C0205447:One [Quantitative Concept]
   753   C0206243:Carrying [Activity]
   719 E C0699809:carry [Finding]

Phrase: "have between a 2540% lifetime chance of developing AD."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0002395:Alzheimers disease [Disease or Syndrome]
   739   C0012634:Disease [Disease or Syndrome]
   739   C0237506:Chance [Qualitative Concept]
   739   C3154893:Have [Idea or Concept]
   739   C3539897:Have [Qualitative Concept]
Processing 00000000.tx.41: In a meta-analysis of Apo E and AD studies, women who have at least one e4 allele appear to be at greater risk for AD, with the strongest effects occurring between age 5075 yr (16). 

Phrase: "In a meta-analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]

Phrase: "of Apo E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "AD studies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0002395:Alzheimers disease [Disease or Syndrome]

Phrase: "women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "who"

Phrase: "have at least one e4 allele"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0002085:Allele [Gene or Genome]
   753   C0205447:One [Quantitative Concept]
   753   C3154893:Have [Idea or Concept]
   753   C3539897:Have [Qualitative Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be at greater risk"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0035647:Risk [Qualitative Concept]
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   770   C2987476:Be [Conceptual Entity]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "for AD,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "with the strongest effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "occurring between age 5075 yr (16"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0001779:Age [Organism Attribute]
   753   C0439234:yr [Temporal Concept]
   719   C1709305:Occur [Activity]
   719   C2745955:OCCUR [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.42: Caucasian women with the e3/e4 genotype were 1.5 times more likely to develop AD than males with that genotype. 

Phrase: "Caucasian women with the e3/e4 genotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0007457:Caucasian [Population Group]
   748   C0043157:Caucasian [Population Group]
   748   C0043210:Women [Population Group]

Phrase: "were"

Phrase: "1.5 times more likely to"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   827   C0450316:1/5 [Quantitative Concept]
   799   C0040223:times [Temporal Concept]
   799   C0332148:Likely [Qualitative Concept]
   799   C0750492:Likely [Idea or Concept]
   799   C1632851:Times [Quantitative Concept]
   799   C2827734:1+ [Quantitative Concept]
   799   C2981698:1+ [Classification]
   766 E C3541383:Time [Temporal Concept]
   727 E C0442043:Temporal [Spatial Concept]
   727 E C2362314:Temporal [Temporal Concept]

Phrase: "develop"

Phrase: "AD than males"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "with"

Phrase: "that genotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.43: Similar results were seen with women possessing an e2/e4 genotype, but due to sample size considerations they did not reach statistical significance. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "seen with women"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0043210:Women [Population Group]
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "possessing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0850310:possess [Mental or Behavioral Dysfunction]
   966   C3154893:Possess [Idea or Concept]

Phrase: "an e2/e4 genotype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotype [Organism Attribute]

Phrase: "but due to sample size considerations"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0242618:Sample Size [Quantitative Concept]
   790   C0678226:Due to [Functional Concept]
           due
   753   C0233535:but [Mental or Behavioral Dysfunction]
   753   C0370003:Sample [Substance]
   753   C0456389:size [Spatial Concept]
   753   C0518609:considerations [Finding]
   753   C2347026:Sample [Conceptual Entity]
   753   C3146286:Due [Idea or Concept]

Phrase: "they"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "statistical significance."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.44: Apo E does not appear to be as strong an AD risk factor in African-American or Hispanic samples, but among Hispanic women, sex-related trends similar to those in Caucasian samples are detected. 

Phrase: "Apo E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be as strong"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0442821:Strong [Qualitative Concept]
   790   C2987476:Be [Conceptual Entity]
   718 E C0237897:Strength [Quantitative Concept]
   718 E C0808080:Strength [Idea or Concept]
   718 E C1705922:Strength [Qualitative Concept]

Phrase: "an AD risk factor in African-American"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C0850664:disease risk factor [Finding]
   770   C0035648:Risk factor [Quantitative Concept]
   770   C1281905:disease risk [Finding]
   767   C0679238:disease factor [Functional Concept]
   744   C0035647:Risk [Qualitative Concept]
   744   C1521761:Factor [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]

Phrase: "or"

Phrase: "Hispanic samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "but among Hispanic women,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0019576:Hispanic [Population Group]
   770   C0043210:Women [Population Group]
   770   C0086409:Hispanic [Population Group]
   770   C0233535:but [Mental or Behavioral Dysfunction]

Phrase: "sex-related trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040833:trends [Temporal Concept]
   827   C1521798:Trends [Temporal Concept]

Phrase: "similar to those in Caucasian samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "are"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.45: This gender effect was not seen in Japanese women in the meta-analysis study. 

Phrase: "This gender effect"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0079399:Gender [Organism Attribute]
   861   C0804628:Gender [Clinical Attribute]
   861   C1280500:Effect [Qualitative Concept]
   861   C1522384:Gender [Organism Attribute]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "seen in Japanese women"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0043210:Women [Population Group]
   770   C0205397:Seen [Qualitative Concept]
   770   C1556094:Japanese [Population Group]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "in the meta-analysis study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]
   734   C0282458:Meta-Analysis [Intellectual Product]
   734   C0920317:Meta-Analysis [Research Activity]
Processing 00000000.tx.46: The reason for this genetic sexual dimorphism is unclear, but it may represent an interaction with postmenopausal ERT or possibly a sex-specific susceptibility among e3/e4 heterozygotes (17). 

Phrase: "The reason for this genetic sexual dimorphism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392360:Reason [Idea or Concept]

Phrase: "is"

Phrase: "unclear,"

Phrase: "but"

Phrase: "it"

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an interaction with postmenopausal ERT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1704675:Interaction [Functional Concept]
   738   C0814270:interactional therapy [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "a sex-specific susceptibility among e3/e4 heterozygotes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0012655:Susceptibility [Clinical Attribute]
   744   C0220898:Susceptibility [Organism Attribute]
   744   C1264642:Susceptibility [Functional Concept]
   744   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.47: Women with a positive family history and an e4 allele may also have an earlier age at onset (18). 

Phrase: "Women with a positive family history"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0043210:Women [Population Group]

Phrase: "and"

Phrase: "an e4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "may"

Phrase: "also"

Phrase: "have"

Phrase: "an earlier age at onset"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   886   C1833334:Early-onset [Finding]
   875   C0206132:age onset [Quantitative Concept]
   812   C0001779:Age [Organism Attribute]
   812   C0332162:Onset [Qualitative Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.48: Environmental risk factors Besides aging, a large number of environmental risk factors have been investigated. 

Phrase: "Environmental risk factors Besides aging,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0686732:environmental risk factors [Qualitative Concept]
       E   Environmental Factor
   806   C0035648:risk factors [Quantitative Concept]
   806   C1553898:risk factors [Idea or Concept]
   797   C0001783:ageing factors [Temporal Concept]
   797   C1516998:Environmental Factors [Functional Concept]
   760   C0035647:Risk [Qualitative Concept]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "a large number of environmental risk factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.49: Particular interest has focused on whether certain exposures may be protective, such as the relationship of education to the concept of functional neuronal reserve, and the commonly held idea of "use it or lose it." 

Phrase: "Particular interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0543488:Interest [Mental Process]

Phrase: "has"

Phrase: "focused on"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0205234:Focused [Spatial Concept]
   833   C1285542:focused [Functional Concept]

Phrase: "whether"

Phrase: "certain exposures"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0274281:exposures [Injury or Poisoning]
   861   C0728853:exposures [Phenomenon or Process]
   827 E C0332157:Exposure [Clinical Attribute]

Phrase: "may"

Phrase: "be"

Phrase: "protective,"

Phrase: "such as the relationship"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439849:Relationship [Qualitative Concept]
  1000   C1705630:Relationship [Idea or Concept]
  1000   C1706279:Relationship [Idea or Concept]
  1000   C3540605:Relationship [Intellectual Product]

Phrase: "of education"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0013621:Education [Educational Activity]
  1000   C0013622:education [Classification]
  1000   C0013658:Education, NOS [Finding]
  1000   C0039401:Education [Educational Activity]
   928 E C1555905:Educational [Intellectual Product]

Phrase: "to the concept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178566:concept [Idea or Concept]

Phrase: "of functional neuronal reserve,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347957:Reserve [Activity]

Phrase: "and"

Phrase: "the commonly held idea of """

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "it"

Phrase: "or"

Phrase: "lose"

Phrase: "it."""
Processing 00000000.tx.50: The results of epidemiological studies are inconsistent, but protective risk factors may include postmenopausal ERT, smoking, more education, and chronic exposure to nonsteroidal antiinflammatory medications. 

Phrase: "The results of epidemiological studies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results studies [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "are"

Phrase: "inconsistent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442809:Inconsistent [Qualitative Concept]

Phrase: "but"

Phrase: "protective risk factors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0679688:protective factors [Biologic Function]
   901   C0035648:risk factors [Quantitative Concept]
   901   C1553898:risk factors [Idea or Concept]
   827   C0035647:Risk [Qualitative Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "may"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "postmenopausal ERT,"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   923   C0014935:Estrogen Replacement Therapy [Therapeutic or Preventive Procedure]
           Estrogen Replacement
   875   C0279494:estrogen therapy [Therapeutic or Preventive Procedure]
   861   C0086258:Estrogen Replacement [Therapeutic or Preventive Procedure]
   861   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C0035139:Replacement [Therapeutic or Preventive Procedure]
   812   C0039798:therapy [Functional Concept]
   812   C0087111:Therapy [Therapeutic or Preventive Procedure]
   812   C0559956:Replacement [Functional Concept]
   812   C1363945:Therapy [Finding]
   812   C1555302:Replacement [Idea or Concept]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "smoking"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0037369:Smoking [Individual Behavior]
  1000   C0453996:Smoking [Individual Behavior]
  1000   C1881674:SMOKING [Phenomenon or Process]
   966 E C0037366:Smoke [Environmental Effect of Humans,Hazardous or Poisonous Substance]
   966 E C0439994:Smoke [Hazardous or Poisonous Substance]

Phrase: ","

Phrase: "more education,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0013621:Education [Educational Activity]
   861   C0013622:education [Classification]
   861   C0013658:Education, NOS [Finding]
   861   C0039401:Education [Educational Activity]
   789 E C1555905:Educational [Intellectual Product]

Phrase: "and"

Phrase: "chronic exposure to nonsteroidal antiinflammatory medications."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332157:Exposure to [Clinical Attribute]
           Exposure
   753   C0205191:chronic [Temporal Concept]
   753   C0274281:Exposure, NOS [Injury or Poisoning]
Processing 00000000.tx.51: Positive risk factors include history of depression, head injury (particularly in individuals with the Apo E e4 allele), and possibly thyroid disease. 

Phrase: "Positive risk factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0035648:risk factors [Quantitative Concept]
   901   C1553898:risk factors [Idea or Concept]
   827   C0035647:Risk [Qualitative Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "history of depression,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0455503:History of - depression [Finding]
   790   C0019664:History [Occupation or Discipline]
   790   C0019665:history [Intellectual Product]
   790   C0262512:History, NOS [Organism Attribute]
   790   C0262926:History [Finding]
   790   C1705255:History [Conceptual Entity]
   790   C2004062:History [Finding]
   718 E C1552658:Historical [Idea or Concept]
   718 E C1552723:Historical [Idea or Concept]

Phrase: "head injury"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0018674:Head injury [Injury or Poisoning]
   861   C0018670:Head [Body Location or Region]
   861   C1281590:Head [Body Part, Organ, or Organ Component]
   861   C1706305:Head [Manufactured Object]
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]
   805 E C0205096:Cephalic [Spatial Concept]

Phrase: "(particularly in individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0027361:Individual [Population Group]
   756   C0237401:Individual [Human]

Phrase: "with the Apo E e4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C3642141:Apolipoprotein E4 Allele [Gene or Genome]
   812   C0002085:Allele [Gene or Genome]
   708   C0052201:Apolipoprotein E4 [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "possibly thyroid disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0040128:Thyroid disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0040132:Thyroid, NOS [Body Part, Organ, or Organ Component]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.52: ERT has been shown to be protective for developing AD in a number of studies and appears to be a dose-related phenomenon (19, 20, 21). 

Phrase: "ERT"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0014935:Estrogen Replacement Therapy [Therapeutic or Preventive Procedure]
           Estrogen Replacement
   913   C0279494:estrogen therapy [Therapeutic or Preventive Procedure]
   901   C0086258:Estrogen Replacement [Therapeutic or Preventive Procedure]
   901   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1363945:Therapy [Finding]
   827   C1555302:Replacement [Idea or Concept]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "protective for developing AD"

Phrase: "in a number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a dose-related phenomenon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "(19,"

Phrase: "20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.53: Exposure of only 1 yr postmenopausally appears to provide some risk reduction in terms of both disease development and age of onset, even many years later. 

Phrase: "Exposure of only 1 yr postmenopausally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0274281:Exposure, NOS [Injury or Poisoning]
   753   C0332157:Exposure [Clinical Attribute]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "some risk reduction in terms of both disease development"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1137094:Risk Reduction [Individual Behavior]
   742   C0301630:Reduction [Natural Phenomenon or Process]
   742   C0392756:Reduction [Qualitative Concept]
   742   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "age of onset,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   790   C0001779:Age [Organism Attribute]

Phrase: "even"

Phrase: "many years later."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.54: The crude odds ratio for ERT exposure in the New York, Cleveland, and Baltimore studies has been about 0.4. 

Phrase: "The crude odds ratio for ERT exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0028873:Odds Ratio [Quantitative Concept]
   742   C0456603:Ratio [Quantitative Concept]
   742   C1547037:Ratio [Intellectual Product]

Phrase: "in the New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "and"

Phrase: "Baltimore studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "been"

Phrase: "about 0.4."
Processing 00000000.tx.55: The relative risk reduction from ERT may interact with other risk factors, such as Apo E genotype, smoking, and history of AD in first degree relatives. 

Phrase: "The relative risk reduction from ERT"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0242492:Relative Risk [Quantitative Concept]
   770   C1137094:Risk Reduction [Individual Behavior]
   744   C0035647:Risk [Qualitative Concept]
   744   C0080103:Relative [Family Group]
   744   C0205345:Relative [Qualitative Concept]
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]
   744   C1547039:*Relative [Quantitative Concept]

Phrase: "may"

Phrase: "interact with other risk factors,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0035648:risk factors [Quantitative Concept]
   806   C1553898:risk factors [Idea or Concept]
   760   C0035647:Risk [Qualitative Concept]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "such as Apo E genotype,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "smoking"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0037369:Smoking [Individual Behavior]
  1000   C0453996:Smoking [Individual Behavior]
  1000   C1881674:SMOKING [Phenomenon or Process]
   966 E C0037366:Smoke [Environmental Effect of Humans,Hazardous or Poisonous Substance]
   966 E C0439994:Smoke [Hazardous or Poisonous Substance]

Phrase: ","

Phrase: "and"

Phrase: "history of AD"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   854   C0683519:History of diseases [Finding]
           disease history
   770   C0019664:History [Occupation or Discipline]
   770   C0019665:history [Intellectual Product]
   770   C0262512:History, NOS [Organism Attribute]
   770   C0262926:History [Finding]
   770   C1705255:History [Conceptual Entity]
   770   C2004062:History [Finding]

Phrase: "in first degree relatives."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
  1000   C1518469:First Degree Relatives [Quantitative Concept]
   966 E C1517194:First Degree Relative [Family Group]
   901   C0444502:First degree [Qualitative Concept]
   827   C0080103:Relatives [Family Group]
   827   C0205435:First [Quantitative Concept]
   827   C0441889:Degree [Qualitative Concept]
   827   C0449286:Degree [Quantitative Concept]
   827   C0542560:Degree [Intellectual Product]
   827   C1279901:First [Qualitative Concept]
   827   C1561545:degree [Quantitative Concept]
   827   C2348088:Degree [Quantitative Concept]
   793 E C0205345:Relative [Qualitative Concept]
   793 E C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.56: The public health aspects of this have begun to be investigated, and more study is needed to determine whether agents such as selective estrogen receptor modulators will produce similar effects. 

Phrase: "The public health aspects of this"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1547011:Aspect [Quantitative Concept]
   719   C1879746:Aspect [Qualitative Concept]

Phrase: "have"

Phrase: "begun"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "agents such as selective estrogen receptor modulators"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0014939:Estrogenic Agents [Hormone,Pharmacologic Substance,Steroid]
   714   C0450442:Agent [Chemical Viewed Functionally]
   714   C1254351:Agent [Pharmacologic Substance]
   714   C1521826:Agent [Intellectual Product]

Phrase: "will"

Phrase: "produce"

Phrase: "similar effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.57: Judging from the experience with ERT use in cardiovascular disease and osteoporosis, it may take many years to understand the full implications on a risk-benefit basis, but the impact of AD is often so catastrophic that further study is necessary. 

Phrase: "Judging from the experience"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0221191:Judge [Professional or Occupational Group]

Phrase: "with ERT use"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C0239301:ESTROGEN USE [Finding]
   812   C0042153:use [Functional Concept]
   812   C0457083:Use [Functional Concept]
   812   C1947944:Use [Intellectual Product]
   756   C0014935:Estrogen Replacement Therapy [Therapeutic or Preventive Procedure]
   708   C0279494:estrogen therapy [Therapeutic or Preventive Procedure]

Phrase: "in cardiovascular disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0007222:Cardiovascular disease [Disease or Syndrome]
   861   C0007226:Cardiovascular [Body System]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "osteoporosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029456:Osteoporosis [Disease or Syndrome]

Phrase: "it"

Phrase: "may"

Phrase: "take"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "many years to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the full implications on a risk-benefit basis,"

Phrase: "but"

Phrase: "the impact of AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1825598:IMPACT [Gene or Genome]

Phrase: "is"

Phrase: "often so catastrophic"

Phrase: "that further study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "necessary."
Processing 00000000.tx.58: The role of ERT in acute treatment of established AD is discussed below. 

Phrase: "The role of ERT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in acute treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "of established AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0002395:Alzheimers disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "discussed below."
Processing 00000000.tx.59: The biology of how ERT can modify AD development is complex, with probably several components interacting. 

Phrase: "The biology of how ERT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0005532:Biology [Biomedical Occupation or Discipline]
   738   C0005527:Biologic Therapy [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "AD development"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0243107:development [Physiologic Function]
   827   C0678723:Development [Organism Function]
   827   C1527148:Development [Functional Concept]
   755 E C0458003:Developmental [Qualitative Concept]
   734   C0002395:Alzheimers disease [Disease or Syndrome]

Phrase: "is"

Phrase: "complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "with probably several components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0449432:Components [Manufactured Object]
   793 E C1705248:Component [Conceptual Entity]

Phrase: "interacting."
Processing 00000000.tx.60: These include the importance of estrogen in normal brain development, the presence of estrogen receptors in brain areas important to memory systems such as hippocampus, estrogen-induced changes in Apo E messenger ribonucleic acid expression, increased cerebral blood flow, trophic effects on neuronal systems, and interactions with the basal forebrain cholinergic system, which degenerates in AD and is a major therapeutic target for treatment. 

Phrase: "These"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the importance of estrogen"

Phrase: "in normal brain development,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   913   C1821244:Normal development [Finding]
   901   C1160340:brain development [Organ or Tissue Function]
   827   C0243107:development [Physiologic Function]
   827   C0678723:Development [Organism Function]
   827   C1527148:Development [Functional Concept]
   755 E C0458003:Developmental [Qualitative Concept]

Phrase: "the presence of estrogen receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in brain areas"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0205146:areas [Spatial Concept]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C0017446:Area [Geographic Area]

Phrase: "important to memory systems"

Phrase: "such as hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "estrogen-induced changes in Apo E messenger ribonucleic acid expression,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   739   C0392747:changes [Functional Concept]
   739   C0443172:changes [Quantitative Concept]
   706 E C1705241:Change [Quantitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "cerebral blood flow,"
Meta Candidates (Total=14; Excluded=7; Pruned=0; Remaining=7)
  1000   C0007818:Cerebral Blood Flow [Organ or Tissue Function]
  1000   C0373440:cerebral blood flow [Diagnostic Procedure]
   901   C0232338:Blood flow [Organism Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0229664:Blood [Body Substance]
   827   C0806140:Flow [Natural Phenomenon or Process]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "trophic effects on neuronal systems,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "interactions with the basal forebrain cholinergic system,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C2266879:Cholinergic Interactions [Molecular Function]
   714   C1704675:Interaction [Functional Concept]

Phrase: "which"

Phrase: "degenerates in AD"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C0011164:degenerate [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1880269:Degenerate [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "is"

Phrase: "a major therapeutic target for treatment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1521840:Target [Functional Concept]
   753   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.61: Estrogens have been shown to be involved in axonal elongation, enhancing the outgrowth of nerve cell processes in vitro and promoting the formation of synapses and dendritic spines Clinical features The clinical expression of AD is quite variable, with diagnostic criteria requiring a mixture of memory deficits in addition to deficits in other aspects of cognition, such as language, praxis, agnosia, or executive function disturbance (e.g. planning, abstraction, and judgment). 

Phrase: "Estrogens"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   966 E C2936882:Estrogen [Pharmacologic Substance]
   916 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in axonal elongation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1314939:Involved [Functional Concept]

Phrase: "enhancing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2349975:Enhance [Activity]

Phrase: "the outgrowth of nerve cell processes"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "promoting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promoting [Activity]

Phrase: "the formation of synapses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C0597545:synapse formation [Organ or Tissue Function]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "dendritic spines"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0872341:Dendritic Spines [Cell Component]
   861   C0011305:Dendritic [Cell Component]
   861   C0037949:spines [Body Part, Organ, or Organ Component]
   861   C0439640:Dendritic [Qualitative Concept]
   827 E C1267072:Spine [Body Part, Organ, or Organ Component]
   827 E C1280065:Spine [Body Part, Organ, or Organ Component]
   827 E C2752558:spine [Cell Component]
   777 E C0521329:Spinal [Spatial Concept]

Phrase: "Clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1521970:Feature [Qualitative Concept]
  1000   C1706388:Feature [Conceptual Entity]
  1000   C2346469:Feature [Qualitative Concept]
  1000   C2348519:Feature [Qualitative Concept]

Phrase: "The clinical expression of AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "quite variable,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:Variable [Qualitative Concept]

Phrase: "with diagnostic criteria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0679228:diagnostic criteria [Intellectual Product]
   861   C0243161:criteria [Intellectual Product]

Phrase: "requiring"

Phrase: "a mixture of memory deficits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439962:Mixture [Substance]

Phrase: "in addition to deficits"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2987487:deficits [Qualitative Concept]
   966 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "in other aspects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1547011:Aspect [Quantitative Concept]
   966   C1879746:Aspect [Qualitative Concept]

Phrase: "of cognition,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009240:Cognition [Mental Process]
   916 E C2981149:Intellect [Mental Process]
   907 E C0233698:Noesis [Mental or Behavioral Dysfunction]

Phrase: "such as language,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023008:Language [Language]

Phrase: "praxis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1864829:Praxis [Finding]
  1000   C3463950:Praxis [Eukaryote]

Phrase: "agnosia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001816:Agnosia [Mental or Behavioral Dysfunction]
  1000   C3463964:Agnosia [Eukaryote]

Phrase: "or"

Phrase: "executive function disturbance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   865   C0277785:Functional disturbance [Qualitative Concept]
   827   C2699787:Disturbance [Qualitative Concept]
   734   C0935584:Executive Function [Mental Process]

Phrase: "("

Phrase: "e.g. planning,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032074:Planning [Mental Process]
  1000   C1301732:Planning [Functional Concept]

Phrase: "abstraction,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0679195:Abstraction [Intellectual Product]
   928 E C0000857:Abstract [Occupational Activity]
   928 E C0600678:Abstract [Intellectual Product]
   928 E C1552863:Abstract [Idea or Concept]

Phrase: "and"

Phrase: "judgment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022423:Judgement [Mental Process]

Phrase: ")."
Processing 00000000.tx.62: Behavioral manifestations are common and include depression, agitation, delusions, and hallucinations, or anxiety syndromes. 

Phrase: "Behavioral manifestations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205319:manifestations [Functional Concept]
   861   C1280464:manifestations [Qualitative Concept]

Phrase: "are"

Phrase: "common"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205214:Common [Quantitative Concept]
  1000   C1522138:Common [Functional Concept]
  1000   C3245511:common [Intellectual Product]

Phrase: "and"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "depression,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0011570:Depression [Mental or Behavioral Dysfunction]
  1000   C0011581:Depression [Mental or Behavioral Dysfunction]
  1000   C0344315:Depression [Finding]
  1000   C0349217:depression nos [Mental or Behavioral Dysfunction]
  1000   C0460137:Depression [Functional Concept]
   928 E C0549249:DEPRESSED [Finding]

Phrase: "agitation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085631:Agitation [Sign or Symptom]

Phrase: "delusions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011253:Delusions [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "hallucinations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018524:Hallucinations [Mental or Behavioral Dysfunction]

Phrase: "or"

Phrase: "anxiety syndromes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0003467:Anxiety [Mental Process]
   861   C0003469:Anxiety [Mental or Behavioral Dysfunction]
   861   C0039082:Syndromes [Disease or Syndrome]
   861   C1558916:SYNDROMES [Finding]
Processing 00000000.tx.63: Sleep disorders and purposeless behaviors such as pacing may also occur in individual patients. 

Phrase: "Sleep disorders"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0037317:sleep disorders [Sign or Symptom]
  1000   C0851578:Sleep Disorders [Disease or Syndrome]
   861   C0012634:Disorders [Disease or Syndrome]
   861   C0037313:Sleep [Organism Function]
   789 E C0013144:Sleepy [Finding]
   761 E C2830004:SLEEPINESS [Finding]

Phrase: "and"

Phrase: "purposeless behaviors such as pacing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0004927:Behaviors [Individual Behavior]
   760   C0677505:behaviors [Finding]
   726 E C2707008:Behavior [Clinical Attribute]

Phrase: "may"

Phrase: "also"

Phrase: "occur in individual patients."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0027361:Individual [Population Group]
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0237401:Individual [Human]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.64: Few studies have addressed the gender specificity of clinical expression. 

Phrase: "Few studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "the gender specificity of clinical expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]
Processing 00000000.tx.65: Studies of gender difference in AD need to be interpreted cautiously in light of underlying gender differences in lateralization and visual-spatial and language abilities occurring in normal development. 

Phrase: "Studies of gender difference"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "in AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "interpreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285553:interpreted [Functional Concept]

Phrase: "cautiously in light of underlying gender differences"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0036866:gender differences [Organism Attribute]
   748   C0023693:Light [Natural Phenomenon or Process]
   748   C0079399:Gender [Organism Attribute]
   748   C0804628:Gender [Clinical Attribute]
   748   C1306462:Light [Functional Concept]
   748   C1522384:Gender [Organism Attribute]
   748   C1881376:Light [Qualitative Concept]
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "in lateralization"

Phrase: "and"

Phrase: "visual-spatial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428114:spatial [Gene or Genome]

Phrase: "and"

Phrase: "language abilities"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1145677:language ability [Mental Process]
   861   C0085732:Abilities [Organism Attribute]
   777 E C1299581:Able [Finding]

Phrase: "occurring in normal development."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1821244:Normal development [Finding]
   770   C0205307:Normal [Qualitative Concept]
   770   C0243107:development [Physiologic Function]
   770   C0439166:% normal [Quantitative Concept]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]
   770   C2347086:% Normal [Quantitative Concept]
   737   C1709305:Occur [Activity]
   737   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.66: In a longitudinal study of AD patients compared to normal elderly, female AD patients performed worse than male AD patients on tests of naming, vocabulary, and word recognition skills, but not on syntactic measures (22). 

Phrase: "In a longitudinal study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023981:Longitudinal Study [Research Activity]
   861   C0205127:Longitudinal [Spatial Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "of AD patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0002395:Alzheimers disease [Disease or Syndrome]

Phrase: "compared to normal elderly,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0001792:Elderly [Population Group]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1707455:Compared [Activity]
   770   C1999167:elderly [Population Group]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "female AD patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C0150905:female patients [Organism Attribute]
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "worse than male AD patients"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0332271:worse [Qualitative Concept]
   753   C1279889:Worse [Finding]
   753   C1457868:Worse [Qualitative Concept]
   719 E C0205169:Bad [Qualitative Concept]
   719 E C0231218:Ill [Sign or Symptom]

Phrase: "on tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0022885:Tests [Laboratory Procedure]
  1000   C0392366:Tests [Intellectual Product]
   966 E C0039593:Test [Functional Concept]

Phrase: "of naming,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0233735:Naming [Mental Process]
   966 E C0027365:Name [Intellectual Product]
   966 E C1547383:Name [Intellectual Product]

Phrase: "vocabulary,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042926:Vocabulary [Intellectual Product]

Phrase: "and"

Phrase: "word recognition skills,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0678856:skills [Individual Behavior]
   734   C0871615:Word Recognition [Mental Process]
   734   C3538907:Word Recognition [Intellectual Product]

Phrase: "but"

Phrase: "not on syntactic measures"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0079809:Measures [Quantitative Concept]
   770   C0597547:syntactic [Idea or Concept]
   770   C1518422:Not [Functional Concept]
   770   C1879489:Measures [Functional Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.67: These deficits persisted during longitudinal follow-up and contrast with no gender differences in these measures in normal elderly. 

Phrase: "These deficits"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2987487:deficits [Qualitative Concept]
   966 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "persisted during longitudinal follow-up"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0589120:Follow-up [Finding]
   806   C1522577:follow-up [Health Care Activity]
   806   C1704685:FOLLOW-UP [Intellectual Product]
   806   C3274571:FOLLOW-UP [Health Care Activity]
   760   C0205127:Longitudinal [Spatial Concept]
   760   C0332283:follow [Temporal Concept]
   760   C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "contrast with no gender differences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1979874:Contrast [Qualitative Concept]

Phrase: "in these measures"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0079809:Measures [Quantitative Concept]
  1000   C1879489:Measures [Functional Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "in normal elderly."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001792:Elderly [Population Group]
   861   C1999167:elderly [Population Group]
Processing 00000000.tx.68: Henderson and Buckwalter (23, 24) also found gender differences on the Mini-Mental status examination score related to language dysfunction. 

Phrase: "Henderson"

Phrase: "and"

Phrase: "Buckwalter"

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")"

Phrase: "also found gender differences on the Mini-Mental status examination score"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0036866:gender differences [Organism Attribute]
   704   C1705241:*Difference [Quantitative Concept]
   704   C1705242:Difference [Qualitative Concept]

Phrase: "related to language dysfunction."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0023008:Language [Language]
   770   C0031847:dysfunction [Functional Concept]
   770   C0277785:Dysfunction, NOS [Qualitative Concept]
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   737 E C0163712:Relate [Organic Chemical]
   715 E C0231174:Malfunction [Functional Concept]
   715 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.69: No gender differences were found using the Blessed test (a cognitive screening instrument), and the rate of deterioration was similar in both sexes (25). 

Phrase: "No gender differences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0036866:gender differences [Organism Attribute]
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Blessed test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]

Phrase: "("

Phrase: "a cognitive screening instrument"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0348000:Instrument [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the rate of deterioration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0871208:Rate [Activity]
   770   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "similar in both sexes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.70: The biological basis for this difference in language abilities in AD may be due to several factors. 

Phrase: "The biological basis for this difference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1527178:Basis [Functional Concept]
   753   C1874451:Basis [Pharmacologic Substance]

Phrase: "in language abilities"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1145677:language ability [Mental Process]
   861   C0085732:Abilities [Organism Attribute]
   777 E C1299581:Able [Finding]

Phrase: "in AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "may"

Phrase: "be due to several factors."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0678226:Due to [Functional Concept]
           due
   760   C2987476:Be [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.71: AD women have a much stronger correlation of disease state with postdexamethasone cortisol levels than men (26). 

Phrase: "AD women"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0043210:Women [Population Group]
   734   C0002395:Alzheimers disease [Disease or Syndrome]

Phrase: "have"

Phrase: "a much stronger correlation of disease state"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1707520:Correlation [Qualitative Concept]

Phrase: "with postdexamethasone cortisol levels"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   901   C0428396:cortisol levels [Laboratory or Test Result]
   884 E C0201968:Cortisol level [Laboratory Procedure]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "than men (26"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0025266:Men [Population Group]
   827 E C0024554:MAN [Finding]
   827 E C0086418:Man [Human]

Phrase: ")."
Processing 00000000.tx.72: Regional cerebral blood flows measured by positron emission tomography in AD have been described, with women having higher mean nonweighted metabolic rates than men (27). 

Phrase: "Regional cerebral blood flows"
Meta Candidates (Total=18; Excluded=7; Pruned=0; Remaining=11)
   923   C0034965:Regional Blood Flows [Organ or Tissue Function]
   890   C0007818:Cerebral Blood Flow [Organ or Tissue Function]
   890   C0373440:cerebral blood flow [Diagnostic Procedure]
   861   C0232338:blood flows [Organism Function]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0205147:regional [Spatial Concept]
   812   C0205276:Regional [Spatial Concept]
   812   C0229664:Blood [Body Substance]
   812   C0806140:flows [Natural Phenomenon or Process]
   812   C1947913:Regional [Spatial Concept]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]

Phrase: "measured by positron emission tomography"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   862   C0032743:Positron-Emission Tomography [Diagnostic Procedure]
   760   C0032744:Positron [Quantitative Concept]
   760   C0040395:tomography [Diagnostic Procedure]
   760   C0040405:tomography [Diagnostic Procedure]
   760   C0233929:Emission [Body Substance]
   760   C0444706:Measured [Qualitative Concept]
   760   C2349995:Emission [Substance]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "in AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: ","

Phrase: "with women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "having"

Phrase: "higher mean nonweighted metabolic rates than men (27"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0870882:metabolic rates [Physiologic Function]
   744   C0311400:Metabolic [Functional Concept]
   744   C1524026:Metabolic [Cell Function]
   744   C2707259:Metabolic [Clinical Attribute]
   711   C0871208:Rate [Activity]
   711   C1521828:Rate [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.73: The explanations for these phenomena include differences in the regional pattern of cell loss and -amyloid deposition, which is coupled to regional cerebral blood flow. 

Phrase: "The explanations for these phenomena"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0681841:Explanations [Intellectual Product]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "differences in the regional pattern of cell loss"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0682132:regional differences [Finding]
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: "and -"

Phrase: "amyloid deposition,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011560:Amyloid deposition [Pathologic Function]
  1000   C1705760:Amyloid Deposition [Finding]
   861   C0333562:Deposition [Functional Concept]

Phrase: "which"

Phrase: "is"

Phrase: "coupled to regional cerebral blood flow."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C0007818:Cerebral Blood Flow [Organ or Tissue Function]
   833   C0373440:cerebral blood flow [Diagnostic Procedure]
   820   C0034965:Regional Blood Flow [Organ or Tissue Function]
   790   C0232338:Blood flow [Organism Function]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0205147:regional [Spatial Concept]
   753   C0205276:Regional [Spatial Concept]
   753   C0229664:Blood [Body Substance]
   753   C0806140:Flow [Natural Phenomenon or Process]
   753   C1947913:Regional [Spatial Concept]
   753   C1948027:Coupled [Functional Concept]
   719 E C0010222:couple [Family Group]
Processing 00000000.tx.74: Dexamethasone resistance has been associated with damage to the hippocampal formation, which is intimately involved in short term memory processing (28). 

Phrase: "Dexamethasone resistance"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "has"

Phrase: "been"

Phrase: "associated with damage"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0010957:Damage [Injury or Poisoning]
   790   C1883709:Damage [Functional Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "to the hippocampal formation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175202:Hippocampal Formation [Body Part, Organ, or Organ Component]
   861   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "which"

Phrase: "is"

Phrase: "intimately"

Phrase: "involved in short term memory processing"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0025265:Memory, Short-Term [Mental Process]
   790   C0443303:Short-term [Temporal Concept]
   790   C0679052:memory processing [Mental Process]
   753   C0025260:Memory [Mental Process]
   753   C0700327:memory [Finding]
   753   C1282927:short [Qualitative Concept]
   753   C1314939:Involved [Functional Concept]
   753   C1515273:Term [Temporal Concept]
   753   C1705313:Term [Idea or Concept]
   753   C1706377:Memory [Manufactured Object]
   753   C1709694:Processing [Activity]
   753   C1806781:Short [Quantitative Concept]
   753   C2350002:Short [Quantitative Concept]
   753   C2826302:TERM [Intellectual Product]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.75: Baseline differences in neural organization, such as increased lateralization in males, may influence patterns of language breakdown, becoming magnified with disease progression. 

Phrase: "Baseline differences in neural organization,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "such as increased lateralization"

Phrase: "in males,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0024554:Males [Finding]
  1000   C0086582:Males [Population Group]
   966 E C1706180:Male [Qualitative Concept]
   966 E C1706428:Male [Qualitative Concept]
   966 E C1706429:Male [Organism Attribute]

Phrase: "may"

Phrase: "influence"

Phrase: "patterns of language breakdown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449774:Patterns [Spatial Concept]

Phrase: "becoming"

Phrase: "magnified with disease progression."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0242656:Disease Progression [Pathologic Function]
           progression
   833   C1947900:Disease progression NOS [Finding]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0449258:Progression [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.76: The Nun study also showed the importance of early life experiences and possible interactions with genetic background. 

Phrase: "The Nun"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0326848:Nun, NOS [Bird]
  1000   C0699944:nun [Professional or Occupational Group]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "also"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the importance of early life experiences"

Phrase: "and"

Phrase: "possible interactions with genetic background."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.77: Linguistic abilities, as measured by an analysis of idea density and grammatical complexity in an autobiographical essay written on entrance to a convent, predicted late life cognitive outcome. 

Phrase: "Linguistic abilities,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Abilities [Organism Attribute]
   777 E C1299581:Able [Finding]

Phrase: "as"

Phrase: "measured by an analysis of idea density"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0178587:density [Quantitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "grammatical complexity in an autobiographical essay"

Phrase: "written on entrance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0337095:Entrance [Spatial Concept]
   756   C0043266:write [Occupation or Discipline]
   756   C1576875:Write [Finding]
   756   C2584304:Write [Mental Process]

Phrase: "to a convent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0563023:Convent [Manufactured Object]

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "late life cognitive outcome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1274040:Outcome [Functional Concept]
Processing 00000000.tx.78: Among 14 sisters who died, AD was present in all with low linguistic ability but in none of those with a high degree of linguistic complexity (29). 

Phrase: "Among 14 sisters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337514:Sisters [Family Group]

Phrase: "who"

Phrase: "died"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0011065:Died [Organism Function]
  1000   C1546956:Died [Finding]
   928 E C0231800:Expired [Organ or Tissue Function]
   928 E C1704631:Expire [Idea or Concept]
   907 E C0184532:dying [Organism Function]
   907 E C1553404:terminated [Idea or Concept]
   907 E C2348570:Terminated [Functional Concept]

Phrase: ","

Phrase: "AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "present in all"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "with low linguistic ability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085732:Ability [Organism Attribute]
   755 E C1299581:Able [Finding]

Phrase: "but in none of those with a high degree of linguistic complexity"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   736   C0023741:Linguistic [Occupation or Discipline]
   736   C0205250:High [Qualitative Concept]
   736   C0233535:but [Mental or Behavioral Dysfunction]
   736   C0441889:Degree [Qualitative Concept]
   736   C0449286:Degree [Quantitative Concept]
   736   C0456148:None [Quantitative Concept]
   736   C0542560:Degree [Intellectual Product]
   736   C0549184:None [Quantitative Concept]
   736   C1299351:High [Qualitative Concept]
   736   C1561545:degree [Quantitative Concept]
   736   C2348088:Degree [Quantitative Concept]
   736   C2700149:HIGH [Intellectual Product]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.79: Noncognitive symptoms may also show gender differences. 

Phrase: "Noncognitive symptoms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0683368:symptoms [Functional Concept]
   861   C1457887:Symptoms [Sign or Symptom]

Phrase: "may"

Phrase: "also"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "gender differences."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0036866:gender differences [Organism Attribute]
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.80: Males tend to have more problems with verbal aggressiveness, preoccupation with bodily function, and apathy. 

Phrase: "Males"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0024554:Males [Finding]
  1000   C0086582:Males [Population Group]
   966 E C1706180:Male [Qualitative Concept]
   966 E C1706428:Male [Qualitative Concept]
   966 E C1706429:Male [Organism Attribute]

Phrase: "tend"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "more problems with verbal aggressiveness,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1546466:Problems [Idea or Concept]
   726 E C0033213:Problem [Finding]

Phrase: "preoccupation with bodily function,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0549165:Preoccupation [Finding]

Phrase: "and"

Phrase: "apathy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085632:Apathy [Sign or Symptom]
Processing 00000000.tx.81: In multiple regression model analysis of the Dementia Behavior Disturbance Scale, there were no gender differences in behavior severity. 

Phrase: "In multiple regression model analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0034980:Regression Analysis [Intellectual Product]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "of the Dementia Behavior Disturbance Scale,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0175659:Scale [Medical Device]
   812   C0349674:Scale [Intellectual Product]
   812   C1947916:Scale [Activity]
   812   C3536777:Scale [Manufactured Object]
   741 E C1710017:Scalar [Qualitative Concept]
   729 E C0222045:Scales [Body Part, Organ, or Organ Component]

Phrase: "there"

Phrase: "were"

Phrase: "no gender differences in behavior severity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036866:gender differences [Organism Attribute]
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.82: However, males scored higher on scales of apathy and vegetative signs, whereas females showed more reclusive behavior and emotional lability, with behaviors such as hoarding, refusing help, and inappropriate laughter and crying (30). 

Phrase: "However,"

Phrase: "males"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0024554:Males [Finding]
  1000   C0086582:Males [Population Group]
   966 E C1706180:Male [Qualitative Concept]
   966 E C1706428:Male [Qualitative Concept]
   966 E C1706429:Male [Organism Attribute]

Phrase: "scored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449820:scored [Quantitative Concept]

Phrase: "higher on scales of apathy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "vegetative signs,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0220912:signs [Functional Concept]
   861   C0220913:signs [Manufactured Object]
   861   C0311392:SIGNS [Finding]
   827 E C1547188:Sign [Idea or Concept]

Phrase: "whereas"

Phrase: "females"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0015780:Females [Finding]
  1000   C0086287:Females [Population Group]
   966 E C0043210:female [Population Group]
   966 E C1705497:Female [Qualitative Concept]
   966 E C1705498:Female [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "more reclusive behavior"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0004927:Behavior [Individual Behavior]
   827   C2707008:Behavior [Clinical Attribute]
   755 E C2986890:Behavioral [Idea or Concept]

Phrase: "and"

Phrase: "emotional lability,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085633:Emotional lability [Mental or Behavioral Dysfunction]

Phrase: "with behaviors"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0004927:Behaviors [Individual Behavior]
  1000   C0677505:behaviors [Finding]
   966 E C2707008:Behavior [Clinical Attribute]
   916 E C2986890:Behavioral [Idea or Concept]

Phrase: "such as hoarding,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0424337:Hoarding [Finding]

Phrase: "refusing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0017095:Refuse [Environmental Effect of Humans]
   966   C1705116:Refuse [Activity]

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: ","

Phrase: "and"

Phrase: "inappropriate laughter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0424304:Inappropriate laughter [Finding]
   861   C0023133:Laughter [Social Behavior]

Phrase: "and"

Phrase: "crying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010399:Crying [Individual Behavior]
   928 E C0424109:WEEPING [Finding]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.83: Differences in baseline behavior may contribute to these findings, and differences in levels of androgens and estrogens may play a role in behavioral expression. 

Phrase: "Differences in baseline behavior"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "may"

Phrase: "contribute to these findings,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C1880177:Contribute [Activity]
   770   C2607943:findings [Functional Concept]
   770   C2926606:Findings [Clinical Attribute]
   770   C3539655:Findings [Intellectual Product]
   737 E C0037088:Finding [Sign or Symptom]
   737 E C0243095:Finding [Finding]
   737 E C2825141:Finding [Finding]

Phrase: "and"

Phrase: "differences in levels of androgens"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "estrogens"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   966 E C2936882:Estrogen [Pharmacologic Substance]
   916 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in behavioral expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.84: The identification of Apo E, its role in cholesterol transport, and its risk factor status for cardiovascular disease have led to a reappraisal of the role of vascular factors in AD. 

Phrase: "The identification of Apo E,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "its role in cholesterol transport,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "its risk factor status for cardiovascular disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449438:Status [Qualitative Concept]

Phrase: "have"

Phrase: "led to a reappraisal of the role of vascular factors"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   743   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   741   C0960756:factor A [Organic Chemical]
   739   C0005847:vascular [Body Part, Organ, or Organ Component]
   739   C0035820:Role [Social Behavior]
   739   C1558950:VASCULAR [Finding]
   739   C1705810:Role [Conceptual Entity]
   739   C1708698:LED [Manufactured Object]
   739   C1801960:Vascular [Qualitative Concept]
   706 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   706 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   706   C1521761:Factor [Functional Concept]
   706 E C1522538:Lead [Functional Concept]
   706 E C2348269:Lead [Element, Ion, or Isotope]
   706   C2827422:Factor [Conceptual Entity]
   706 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in AD."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.85: Although -amyloid is found in meningeal vessels, no consistent evidence of a systemic amyloidosis has been identified in AD. 

Phrase: "Although -"

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "found in meningeal vessels,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0005847:Vessels [Body Part, Organ, or Organ Component]
   770   C0150312:Found [Quantitative Concept]
   770   C0521400:Meningeal [Spatial Concept]
   737 E C0243095:Find [Finding]
   737 E C1511228:Vessel [Tissue]

Phrase: "no consistent evidence of a systemic amyloidosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "has"

Phrase: "been"

Phrase: "identified in AD."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.86: Cerebral ischemia may complicate AD, leading to decrements in neuropsychological performance and faster clinical progression, as suggested by the findings in the Nun study (31). 

Phrase: "Cerebral ischemia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007785:Cerebral Ischemia [Disease or Syndrome]
  1000   C0917798:Cerebral Ischemia [Disease or Syndrome]
   861   C0022116:Ischaemia [Disease or Syndrome]
   789 E C0475224:Ischaemic [Functional Concept]

Phrase: "may"

Phrase: "complicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231242:complicate [Functional Concept]

Phrase: "AD,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "leading to decrements"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0332152:Leading [Temporal Concept]
   790   C1522538:Leading [Functional Concept]
   756 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   756 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   756 E C2348269:Lead [Element, Ion, or Isotope]
   756 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in neuropsychological performance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597198:Performance [Individual Behavior]
   861   C1882330:Performance [Activity]

Phrase: "and"

Phrase: "faster clinical progression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0242656:progression [Pathologic Function]
   827   C0449258:Progression [Functional Concept]

Phrase: "as"

Phrase: "suggested by the findings"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C2607943:findings [Functional Concept]
   770   C2926606:Findings [Clinical Attribute]
   770   C3539655:Findings [Intellectual Product]
   737 E C0037088:Finding [Sign or Symptom]
   737 E C0243095:Finding [Finding]
   737   C1705535:Suggest [Idea or Concept]
   737 E C2825141:Finding [Finding]

Phrase: "in the Nun study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.87: Overall disease survival from onset and diagnosis is variable, but averages between 810 yr. 

Phrase: "Overall disease survival from onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]

Phrase: "and"

Phrase: "diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "is"

Phrase: "variable,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439828:Variable [Qualitative Concept]

Phrase: "but"

Phrase: "averages between 810 yr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1510992:Average [Quantitative Concept]
   737   C2825518:AVERAGE [Quantitative Concept]
Processing 00000000.tx.88: Many investigators have used age at onset or particular clinical features to investigate the possibility of AD subgroups, but these have not been shown to have consistent biological validity. 

Phrase: "Many investigators"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035173:Investigators [Professional or Occupational Group]

Phrase: "have"

Phrase: "used age at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0206132:age onset [Quantitative Concept]
   812   C0001779:Age [Organism Attribute]
   812   C0332162:Onset [Qualitative Concept]

Phrase: "or"

Phrase: "particular clinical features to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C1521970:Feature [Qualitative Concept]
   779   C1706388:Feature [Conceptual Entity]
   779   C2346469:Feature [Qualitative Concept]
   779   C2348519:Feature [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the possibility of AD subgroups,"

Phrase: "but"

Phrase: "these"

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "consistent biological validity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C2349101:Validity [Quantitative Concept]
   755 E C2349099:Valid [Qualitative Concept]
Processing 00000000.tx.89: Factors associated with quicker progression include the presence of family history, onset at an early age, extrapyramidal symptoms, psychosis, and comorbid medical conditions. 

Phrase: "Factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "associated with quicker progression"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]
   737   C0439831:quick [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the presence of family history,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "onset at an early age,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0206132:Onset Age [Quantitative Concept]
   797   C1833334:Early-onset [Finding]
   760   C0332162:Onset [Qualitative Concept]

Phrase: "extrapyramidal symptoms,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0234133:Extrapyramidal symptoms [Sign or Symptom]
   861   C0683368:symptoms [Functional Concept]
   861   C1457887:Symptoms [Sign or Symptom]

Phrase: "psychosis,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033975:Psychosis [Mental or Behavioral Dysfunction]
  1000   C0349204:Psychosis NOS [Mental or Behavioral Dysfunction]
   928 E C0459435:Psychotic [Finding]

Phrase: "and"

Phrase: "comorbid medical conditions."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   913   C1275743:Co-morbid conditions [Finding]
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.90: In our study of two large cohorts, smoking did not affect disease survival (32). 

Phrase: "In our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "of two large cohorts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0599755:cohorts [Population Group]

Phrase: "smoking"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0037369:Smoking [Individual Behavior]
  1000   C0453996:Smoking [Individual Behavior]
  1000   C1881674:SMOKING [Phenomenon or Process]
   966 E C0037366:Smoke [Environmental Effect of Humans,Hazardous or Poisonous Substance]
   966 E C0439994:Smoke [Hazardous or Poisonous Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "disease survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.91: Moritz et al. 

Phrase: "Moritz et al."
Processing 00000000.tx.92: (33) found men had shorter survival times than women, with shorter male survival associated with more psychiatric symptomatology. 

Phrase: "(33"

Phrase: ")"

Phrase: "found men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0025266:Men [Population Group]
   827 E C0024554:MAN [Finding]
   827 E C0086418:Man [Human]

Phrase: "had"

Phrase: "shorter survival times than women,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   773   C2919552:Survival time [Clinical Attribute]
   760   C0038952:Survival [Activity]
   760   C0040223:times [Temporal Concept]
   760   C0220921:survival [Functional Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "with shorter male survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0038952:Survival [Activity]
   827   C0220921:survival [Functional Concept]

Phrase: "associated with more psychiatric symptomatology."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0205487:Psychiatric [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.93: Among women, but not men, a history of cardiovascular disease was associated with poorer survival. 

Phrase: "Among women,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "but"

Phrase: "not men,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0025266:Men [Population Group]
   827 E C0024554:MAN [Finding]
   827 E C0086418:Man [Human]

Phrase: "a history of cardiovascular disease"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   926   C0455539:History of - cardiovascular disease [Finding]
   816   C0683519:History of diseases [Finding]
           disease history
   797   C1880008:Cardiovascular History [Clinical Attribute]
   760   C0019664:History [Occupation or Discipline]
   760   C0019665:history [Intellectual Product]
   760   C0262512:History, NOS [Organism Attribute]
   760   C0262926:History [Finding]
   760   C1705255:History [Conceptual Entity]
   760   C2004062:History [Finding]

Phrase: "was"

Phrase: "associated with poorer survival."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0038952:Survival [Activity]
   770   C0220921:survival [Functional Concept]
   737   C0032854:Poor [Group Attribute]
   737   C0542537:Poor [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   737   C2700379:Poor [Qualitative Concept]
Processing 00000000.tx.94: Treatment The major basis for current pharmacological treatment of AD is based on the cholinergic hypothesis. 

Phrase: "Treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "The major basis for current pharmacological treatment of AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1527178:Basis [Functional Concept]
   739   C1874451:Basis [Pharmacologic Substance]

Phrase: "is"

Phrase: "based on the cholinergic hypothesis."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0599668:cholinergic [Functional Concept]
   760   C1512571:Hypothesis [Idea or Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.95: The cholinergic system radiates from basal forebrain nuclei and degenerates early in AD, and cholinergic markers correlate with disease course. 

Phrase: "The cholinergic system"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0684164:cholinergic system [Biologically Active Substance]
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "radiates from basal forebrain nuclei"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C2331620:Basal forebrain [Body Part, Organ, or Organ Component]
   797   C0004781:Basal Nuclei [Body Part, Organ, or Organ Component]
   797   C1321510:Basal nuclei [Body Part, Organ, or Organ Component]
   781 E C0004788:basal nucleus [Body Part, Organ, or Organ Component]
   760   C0085140:Fore-Brain [Body Part, Organ, or Organ Component]
   760   C0205112:Basal [Spatial Concept]
   760   C0332301:radiate [Functional Concept]
   726   C0007610:Nucleus [Cell Component]

Phrase: "and"

Phrase: "degenerates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011164:degenerate [Pathologic Function]
  1000   C1880269:Degenerate [Functional Concept]

Phrase: "early in AD,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   819   C0679245:early disease [Temporal Concept]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1279919:Early [Temporal Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "cholinergic markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: "correlate with disease course."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0242656:disease course [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0750729:Course [Temporal Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.96: Enhancement of cholinergic function by acetylcholinesterase inhibitors has been demonstrated to improve cognitive functioning compared to the effect of placebo and may have effects on noncognitive symptoms and vegetative symptoms as well (34, 35). 

Phrase: "Enhancement of cholinergic function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   770   C2349975:Enhancement [Activity]

Phrase: "by acetylcholinesterase inhibitors"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0001046:Acetylcholinesterase Inhibitors [Pharmacologic Substance]
   983 E C3536756:Acetylcholinesterase Inhibitor [Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "improve"

Phrase: "cognitive functioning"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0392334:cognitive functioning [Mental Process]
  1000   C0392335:Cognitive functioning [Mental Process]
   861   C0542341:functioning [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]

Phrase: "compared to the effect of placebo"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0032041:Placebo Effect [Idea or Concept]
   753   C0032042:placebo [Therapeutic or Preventive Procedure]
   753   C1280500:Effect [Qualitative Concept]
   753   C1696465:placebo [Biomedical or Dental Material]
   753   C1706408:PLACEBO [Research Activity]
   753   C1707455:Compared [Activity]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "may"

Phrase: "have"

Phrase: "effects on noncognitive symptoms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "vegetative symptoms as well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0683368:symptoms [Functional Concept]
   770   C1457887:Symptoms [Sign or Symptom]

Phrase: "(34,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.97: A retrospective review of data from the 30-week tacrine trial (36) showed that the most robust improvements in neuropsychological testing occurred in women with concurrent ERT or recent treatment (within 3 months of trial enrollment) (37). 

Phrase: "A retrospective review of data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0282443:Review [Intellectual Product]
   760   C1552617:Review [Idea or Concept]

Phrase: "from the 30-week tacrine trial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0008976:Trial [Research Activity]

Phrase: "(36"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the most robust improvements in neuropsychological testing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C2986411:Improvement [Conceptual Entity]

Phrase: "occurred in women"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0043210:Women [Population Group]
   790   C1709305:Occurred [Activity]
   756 E C2745955:OCCUR [Temporal Concept]

Phrase: "with concurrent ERT"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   923   C0014935:Estrogen Replacement Therapy [Therapeutic or Preventive Procedure]
           Estrogen Replacement
   902   C0009429:concurrent therapy [Therapeutic or Preventive Procedure]
   875   C0279494:estrogen therapy [Therapeutic or Preventive Procedure]
   861   C0086258:Estrogen Replacement [Therapeutic or Preventive Procedure]
   861   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C0035139:Replacement [Therapeutic or Preventive Procedure]
   812   C0039798:therapy [Functional Concept]
   812   C0087111:Therapy [Therapeutic or Preventive Procedure]
   812   C0559956:Replacement [Functional Concept]
   812   C1363945:Therapy [Finding]
   812   C1555302:Replacement [Idea or Concept]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "recent treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "("

Phrase: "within 3 months"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442461:3 Months [Temporal Concept]
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "of trial enrollment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1516879:Enrollment [Health Care Activity]
   861   C1696073:enrollment [Intellectual Product]

Phrase: ")"

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.98: The cognitive effects of ERT have been investigated in a number of human models since the 1950s. 

Phrase: "The cognitive effects of ERT"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   774   C0877035:Estrogen Effects [Finding]
   757   C1518681:Therapy Effect [Finding]
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "investigated in a number of human models"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C3274659:Model Number [Intellectual Product]
   748   C0086418:Human [Human]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C1292732:investigated [Functional Concept]
   748   C3161035:Models [Intellectual Product]

Phrase: "since"

Phrase: "the 1950s."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681754:1950s [Temporal Concept]
Processing 00000000.tx.99: In surgically or naturally menopausal women, ERT has been associated with enhanced short and long term memory and increased capacity for learning paired associations. 

Phrase: "In surgically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543467:Surgically [Health Care Activity]

Phrase: "or"

Phrase: "naturally menopausal women,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0043210:Women [Population Group]

Phrase: "ERT"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0014935:Estrogen Replacement Therapy [Therapeutic or Preventive Procedure]
           Estrogen Replacement
   913   C0279494:estrogen therapy [Therapeutic or Preventive Procedure]
   901   C0086258:Estrogen Replacement [Therapeutic or Preventive Procedure]
   901   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1363945:Therapy [Finding]
   827   C1555302:Replacement [Idea or Concept]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "associated with enhanced short"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C1282927:short [Qualitative Concept]
   770   C1806781:Short [Quantitative Concept]
   770   C2349975:Enhanced [Activity]
   770   C2350002:Short [Quantitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "long term memory"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0423909:Memory, Long-Term [Mental Process]
   901   C0443252:Long-term [Temporal Concept]
   827   C0025260:Memory [Mental Process]
   827   C0205166:Long [Qualitative Concept]
   827   C0700327:memory [Finding]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C1706377:Memory [Manufactured Object]
   827   C2826302:TERM [Intellectual Product]
   771 E C0679055:mnemonic [Mental Process]

Phrase: "and"

Phrase: "increased capacity for learning paired associations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1516240:Capacity [Quantitative Concept]
Processing 00000000.tx.100: Visual memory, however, does not improve with ERT (38). 

Phrase: "Visual memory,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0542316:Visual memory [Mental Process]
   861   C0025260:Memory [Mental Process]
   861   C0234621:Visual [Functional Concept]
   861   C0700327:memory [Finding]
   861   C1706377:Memory [Manufactured Object]
   805 E C0679055:mnemonic [Mental Process]

Phrase: "however,"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "improve with ERT"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   862   C0014935:Estrogen Replacement Therapy [Therapeutic or Preventive Procedure]
           Estrogen Replacement
   806   C0086258:Estrogen Replacement [Therapeutic or Preventive Procedure]
   806   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   797   C0279494:estrogen therapy [Therapeutic or Preventive Procedure]
   760   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   760   C0035139:Replacement [Therapeutic or Preventive Procedure]
   760   C0039798:therapy [Functional Concept]
   760   C0087111:Therapy [Therapeutic or Preventive Procedure]
   760   C0559956:Replacement [Functional Concept]
   760   C1363945:Therapy [Finding]
   760   C1555302:Replacement [Idea or Concept]
   760   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.101: In women aged 3236 yr old with uterine myomas given a GnRH agonist (GnRH-a) for 12 weeks, verbal memory scores declined significantly. 

Phrase: "In women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "3236 yr old with uterine myomas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0580836:Old [Temporal Concept]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "a GnRH agonist (GnRH-a) for 12 weeks,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0083220:GnRH Agonist [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   753   C2987634:Agonist [Pharmacologic Substance]

Phrase: "verbal memory scores"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449820:Scores [Quantitative Concept]
   734   C0561770:Verbal memory [Mental Process]

Phrase: "declined"

Phrase: "significantly."
Processing 00000000.tx.102: This was followed by GnRH-a with estrogen or placebo, with the former group showing improvements to baseline verbal scores but continued poorer performance in the GnRH-a and placebo cohort. 

Phrase: "This"

Phrase: "was"

Phrase: "followed by GnRH-a"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0083220:GnRH Agonist [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   770   C2987634:Agonist [Pharmacologic Substance]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "with estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "placebo,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032042:placebo [Therapeutic or Preventive Procedure]
  1000   C1696465:placebo [Biomedical or Dental Material]
  1000   C1706408:PLACEBO [Research Activity]

Phrase: "with the former group showing improvements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C2986411:Improvement [Conceptual Entity]

Phrase: "to baseline verbal scores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449820:Scores [Quantitative Concept]

Phrase: "but"

Phrase: "continued"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continued [Idea or Concept]

Phrase: "poorer performance in the GnRH-a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0597198:Performance [Individual Behavior]
   753   C1882330:Performance [Activity]

Phrase: "and"

Phrase: "placebo cohort."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599755:Cohort [Population Group]
Processing 00000000.tx.103: These results suggest that estrogen deprivation effects are reversible with replacement, at least in the short term (39). 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that estrogen deprivation effects"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C0877035:Estrogen Effects [Finding]
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "reversible with replacement,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0205343:Reversible [Functional Concept]
   718 E C0449261:Reversibility [Temporal Concept]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in the short term"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0443303:Short-term [Temporal Concept]
   861   C1282927:short [Qualitative Concept]
   861   C1515273:Term [Temporal Concept]
   861   C1705313:Term [Idea or Concept]
   861   C1806781:Short [Quantitative Concept]
   861   C2350002:Short [Quantitative Concept]
   861   C2826302:TERM [Intellectual Product]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.104: Serum levels of endogenous estrogens are not consistently correlated with cognitive performance in older women (40). 

Phrase: "Serum levels of endogenous estrogens"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   781   C0857965:estrogen serum [Laboratory Procedure]
   760   C0229671:Serum [Body Substance]
   760   C0441889:Levels [Qualitative Concept]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "not consistently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "correlated with cognitive performance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0597198:Performance [Individual Behavior]
   770   C1516691:Cognitive [Functional Concept]
   770   C1707520:Correlated [Qualitative Concept]
   770   C1882330:Performance [Activity]

Phrase: "in older women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043210:Women [Population Group]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.105: Animal studies using paradigms such as ovariectomized animals and standardized behavioral tests have shown a wide variety of interactions of estrogens with cholinergic, dopaminergic, and serotoninergic neurotransmitter systems important for modulating memory, mood, and affect (41, 42, 43, 44, 45). 

Phrase: "Animal studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0683949:animal studies [Animal]
   861   C0003062:Animal [Animal]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "paradigms such as ovariectomized animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0681797:paradigms [Research Activity]

Phrase: "and"

Phrase: "standardized behavioral tests"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   913   C0237892:standardized tests [Intellectual Product]
   884   C0683444:behavioral test [Diagnostic Procedure]
   827   C0022885:Tests [Laboratory Procedure]
   827   C0392366:Tests [Intellectual Product]
   793 E C0039593:Test [Functional Concept]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a wide variety of interactions of estrogens"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1883525:Variety [Conceptual Entity]
   748   C2346866:Variety [Conceptual Entity]

Phrase: "with cholinergic, dopaminergic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282151:Dopaminergic [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "serotoninergic neurotransmitter systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: "important for modulating memory,"

Phrase: "mood,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0026516:Mood [Mental Process]
  1000   C2713234:Mood [Clinical Attribute]
   928 E C0554980:Moody [Finding]
   900 E C0241999:MOODINESS [Mental Process]

Phrase: "and"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "(41,"

Phrase: "42,"

Phrase: "43,"

Phrase: "44,"

Phrase: "45"

Phrase: ")."
Processing 00000000.tx.106: Estrogens also facilitate hippocampal neuronal long term potentiation, a model for memory formation (46); 

Phrase: "Estrogens also"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   827 E C2936882:Estrogen [Pharmacologic Substance]
   777 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "facilitate"

Phrase: "hippocampal neuronal long term potentiation,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   884   C2984294:Long-term potentiation [Functional Concept]
   840   C0443252:Long-term [Temporal Concept]
   804   C0205166:Long [Qualitative Concept]
   804   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   804   C1515273:Term [Temporal Concept]
   804   C1705313:Term [Idea or Concept]
   804   C1706317:Long [Qualitative Concept]
   804   C2826302:TERM [Intellectual Product]

Phrase: "a model for memory formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "(46"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.107: protect against memory-impairing compounds, such as anticholinergics and benzodiazepines (44, 47, 48); 

Phrase: "protect against memory-impairing compounds,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0025260:Memory [Mental Process]
   760   C0221099:impairing [Functional Concept]
   760   C0700327:memory [Finding]
   760   C1706377:Memory [Manufactured Object]
   726   C0205198:Compound [Qualitative Concept]
   726   C1706082:Compound [Chemical]
   704 E C0679055:mnemonic [Mental Process]

Phrase: "such as anticholinergics"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0242896:Anticholinergics [Pharmacologic Substance]
   966 E C3537004:Anticholinergic [Pharmacologic Substance]

Phrase: "and"

Phrase: "benzodiazepines"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0005064:Benzodiazepines [Organic Chemical,Pharmacologic Substance]
   966 E C3536850:Benzodiazepine [Pharmacologic Substance]

Phrase: "(44,"

Phrase: "47,"

Phrase: "48"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.108: and reduce neuronal responses to oxidative stress (49). 

Phrase: "and"

Phrase: "reduce"

Phrase: "neuronal responses to oxidative stress"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   915   C1155312:response to oxidative stress [Cell Function]
   833   C0149784:response to stress [Physiologic Function]
           responses stress
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.109: Human studies have shown conflicting results in longitudinal and cross-sectional studies, with most studies showing only a modest effect on selected neuropsychological variables such as explicit memory or visual-spatial skills, but not immediate memory (50, 51, 52, 53). 

Phrase: "Human studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0178693:human studies [Research Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "conflicting results in longitudinal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "and"

Phrase: "cross-sectional studies,"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
  1000   C0010362:Cross-Sectional Studies [Research Activity]
   865   C0552389:cross sections [Spatial Concept]
   827   C0205155:Sectional [Spatial Concept]
   827   C0947630:studies [Laboratory Procedure]
   827   C2828360:Cross [Conceptual Entity]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   755 E C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   755 E C1522472:Section [Substance]
   755 E C1552923:Section [Quantitative Concept]
   755 E C1705191:Section [Physical Object]

Phrase: "with most studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a modest effect on selected neuropsychological variables"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "such as explicit memory"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0561766:Explicit memory [Mental Process]
   861   C0025260:Memory [Mental Process]
   861   C0700327:memory [Finding]
   861   C1706377:Memory [Manufactured Object]
   805 E C0679055:mnemonic [Mental Process]

Phrase: "or"

Phrase: "visual-spatial skills,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0234621:Visual [Functional Concept]
   827   C0678856:skills [Individual Behavior]
   827   C1428114:spatial [Gene or Genome]

Phrase: "but"

Phrase: "not immediate memory"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0025265:Memory, Immediate [Mental Process]
   827   C0025260:Memory [Mental Process]
   827   C0700327:memory [Finding]
   827   C1706377:Memory [Manufactured Object]
   771 E C0679055:mnemonic [Mental Process]

Phrase: "(50,"

Phrase: "51,"

Phrase: "52,"

Phrase: "53"

Phrase: ")."
Processing 00000000.tx.110: It is likely that the memory-promoting effects of acute estrogen replacement derive from its pleiotropic action in the central nervous system, including interactions with estrogen receptors with changes in gene expression, as well as up-regulation of other neurotransmitter systems, as indicated by extensive data from animal models. 

Phrase: "It"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "the memory-promoting effects of acute estrogen replacement"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0877035:Estrogen Effects [Finding]
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "derive from its pleiotropic action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441472:Action [Functional Concept]
   760   C3266814:Action [Activity]

Phrase: "in the central nervous system,"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "interactions with estrogen receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C1372999:Receptor Interactions [Molecular Function]
   737   C1704675:Interaction [Functional Concept]

Phrase: "with changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "in gene expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "as well as"

Phrase: "up-regulation of other neurotransmitter systems,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0041904:Up-Regulation [Cell Function,Molecular Function]
   790   C0162493:Up-Regulation [Genetic Function]
   753   C0547043:Up [Spatial Concept]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1282911:Up [Spatial Concept]
   753   C1327622:Regulation [Biologic Function]

Phrase: "as"

Phrase: "indicated by extensive data"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205231:Extensive [Qualitative Concept]
   770   C1444656:Indicated [Finding]
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "from animal models."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599779:Models, Animal [Animal]
   861   C0003062:Animal [Animal]
   861   C3161035:Models [Intellectual Product]
Processing 00000000.tx.111: In patients with established cognitive impairment, early open label studies and more recent randomized studies using current AD diagnostic criteria have showed trends toward improvements in several neuropsychological and behavioral ratings. 

Phrase: "In patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with established cognitive impairment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   827   C0684336:Impairment [Pathologic Function]

Phrase: "early open label studies"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   890   C1709323:Open Label Study [Research Activity]
           OPEN LABEL
   812   C0175566:Open [Spatial Concept]
   812   C0181496:Label [Manufactured Object]
   812   C0947630:studies [Laboratory Procedure]
   812   C2827499:Label [Governmental or Regulatory Activity]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]
   741 E C0547049:Openness [Spatial Concept]

Phrase: "and"

Phrase: "more recent randomized studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "current AD diagnostic criteria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0679228:diagnostic criteria [Intellectual Product]
   804   C0243161:criteria [Intellectual Product]

Phrase: "have"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "trends toward improvements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0040833:trends [Temporal Concept]
   790   C1521798:Trends [Temporal Concept]

Phrase: "in several neuropsychological"

Phrase: "and"

Phrase: "behavioral ratings."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0871208:Rating [Activity]
Processing 00000000.tx.112: However, many of these studies have been quite small and of relatively short duration (<6 months) (54). 

Phrase: "However,"

Phrase: "many of these studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0439064:Many [Quantitative Concept]
   770   C0747726:many [Conceptual Entity]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "been"

Phrase: "quite small"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0700321:Small [Quantitative Concept]

Phrase: "and of relatively short duration"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0439593:Short duration [Qualitative Concept]
   760   C0449238:Duration [Temporal Concept]
   760   C1282927:short [Qualitative Concept]
   760   C1515981:And [Idea or Concept]
   760   C1806781:Short [Quantitative Concept]
   760   C2350002:Short [Quantitative Concept]
   760   C2926735:Duration [Pharmacologic Substance]

Phrase: "("

Phrase: "<6 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: ")"

Phrase: "(54"

Phrase: ")."
Processing 00000000.tx.113: A larger, longer, multicenter, randomized, placebo-controlled study in established AD women is underway, and results will be available shortly. 

Phrase: "A larger, longer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0443228:larger [Quantitative Concept]
   861   C0549177:Larger [Quantitative Concept]
   861   C1704243:Larger [Quantitative Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C1706317:Long [Qualitative Concept]

Phrase: "multicenter,"

Phrase: "randomized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034656:randomized [Research Activity]

Phrase: ","

Phrase: "placebo-controlled study in established AD women"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   800   C0599724:placebo-controlled study [Intellectual Product,Research Activity]
   770   C0681867:Controlled Study [Research Activity]
   770   C1706408:placebo-controlled [Research Activity]
           PLACEBO
   767   C0683952:placebo study [Research Activity]
   767   C2911690:Disease Controlled [Finding]
   750 E C0920467:control disease [Therapeutic or Preventive Procedure]
   744   C0032042:placebo [Therapeutic or Preventive Procedure]
   744   C0557651:Study [Manufactured Object]
   744   C1696465:placebo [Biomedical or Dental Material]
   744   C2587213:Controlled [Functional Concept]
   744   C2603343:Study [Research Activity]
   711 E C0243148:control [Qualitative Concept]
   711 E C1550141:Control [Substance]
   711 E C1882979:Control [Conceptual Entity]
   711 E C3274648:Control [Qualitative Concept]

Phrase: "is"

Phrase: "underway,"

Phrase: "and"

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "will"

Phrase: "be"

Phrase: "available shortly."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0470187:Available [Functional Concept]
Processing 00000000.tx.114: Care-giving and AD Implicit in the progressive deterioration of cognitive and self-care abilities in AD is the reality that care will be rendered to assist the patient with activities of daily living. 

Phrase: "Care-giving"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1947933:Care [Activity]
   827   C1947971:Give [Functional Concept]

Phrase: "and"

Phrase: "AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "Implicit in the progressive deterioration of cognitive"

Phrase: "and"

Phrase: "self-care abilities in AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   816   C0562734:Self-care ability [Finding]
   753   C0085732:Abilities [Organism Attribute]

Phrase: "is"

Phrase: "the reality"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0871222:reality [Idea or Concept]
   928 E C0237400:Real [Qualitative Concept]
   928 E C3272377:REAL [Intellectual Product]

Phrase: "that care"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947933:Care [Activity]

Phrase: "will"

Phrase: "be"

Phrase: "rendered"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assist"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:assist [Social Behavior]
  1000   C0557034:assist [Health Care Activity]

Phrase: "the patient with activities of daily living."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030705:*^patient [Patient or Disabled Group]
Processing 00000000.tx.115: Even in the United States, with its well developed system of long term care facilities for dementia patients, it is estimated that 80% of care occurs in the informal home setting. 

Phrase: "Even in the United States,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0041703:United States [Geographic Area]
   760   C1301808:states [Geographic Area]
   726   C0166872:unite [Biomedical or Dental Material]
   726 E C1442792:State [Functional Concept]
   726 E C3148680:State [Geographic Area]

Phrase: "with its well developed system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "of long term care facilities"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   966   C1708733:Long-Term Care Facility [Health Care Related Organization]
   923   C0023977:long-term care [Health Care Activity]
   923   C1547194:Long Term Care [Health Care Related Organization]
   923   C1552238:Long-Term Care [Professional or Occupational Group]
   861   C0443252:Long-term [Temporal Concept]
   812   C0205166:Long [Qualitative Concept]
   812   C1515273:Term [Temporal Concept]
   812   C1705313:Term [Idea or Concept]
   812   C1706317:Long [Qualitative Concept]
   812   C1947933:Care [Activity]
   812   C2826302:TERM [Intellectual Product]
   779   C1547538:Facility [Idea or Concept]

Phrase: "for dementia patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "it"

Phrase: "is"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "that 80% of care"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1947933:Care [Activity]

Phrase: "occurs in the informal home setting."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0442519:Home [Conceptual Entity]
   753   C0542559:setting [Functional Concept]
   753   C1318139:{Setting} [Quantitative Concept]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.116: The most consistent finding in care-giving research is that the majority of family care-givers are women, providing approximately two thirds of care for AD patients. 

Phrase: "The most consistent finding in care-giving research"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0037088:Finding [Sign or Symptom]
   744   C0243095:Finding [Finding]
   744   C2825141:Finding [Finding]
   735   C0332529:Consistency finding [Qualitative Concept]

Phrase: "is"

Phrase: "that"

Phrase: "the majority of family care-givers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680220:majority [Social Behavior]

Phrase: "are"

Phrase: "women,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "approximately two thirds of care"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205437:Third [Quantitative Concept]
   760   C0205448:Two [Quantitative Concept]

Phrase: "for AD patients."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0002395:Alzheimers disease [Disease or Syndrome]
Processing 00000000.tx.117: This compares to 8090% of care provided by women among adult child care-givers. 

Phrase: "This"

Phrase: "compares to 8090% of care"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1707455:Compare [Activity]
   760   C1947933:Care [Activity]

Phrase: "provided by women"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0043210:Women [Population Group]
   790   C1999230:Provided [Activity]

Phrase: "among adult child care-givers."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0085537:Care Givers [Professional or Occupational Group]
   844 E C1546494:Care giver [Idea or Concept]
   708   C1171177:Adult care [Therapeutic or Preventive Procedure]
Processing 00000000.tx.118: In studying the content of care-giving, women are more likely than men to carry out personal care activities, such as bathing, dressing, or personal hygiene. 

Phrase: "In studying"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the content of care-giving,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0423896:Content [Mental Process]
   760   C0456205:Content [Conceptual Entity]

Phrase: "women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "are"

Phrase: "more likely than men to"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0025266:Men [Population Group]
   760   C0205172:More [Functional Concept]
   760   C0332148:Likely [Qualitative Concept]
   760   C0750492:Likely [Idea or Concept]
   726 E C0024554:MAN [Finding]
   726 E C0086418:Man [Human]

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "out personal care activities,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   923   C0563471:Personal care activities [Daily or Recreational Activity]
   844   C1947933:care activity [Activity]
   812   C0441655:Activities [Activity]
   779 E C0205177:Activity [Functional Concept]
   779 E C0439167:% activity [Quantitative Concept]
   779 E C1561536:*Activity [Idea or Concept]

Phrase: "such as bathing,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0150141:Bathing [Therapeutic or Preventive Procedure]
  1000   C0518460:Bathing [Finding]
  1000   C0541747:bathing [Therapeutic or Preventive Procedure]

Phrase: "dressing"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0013119:Dressing [Medical Device]
  1000   C0278286:Dressing [Therapeutic or Preventive Procedure]
  1000   C0518459:dressing [Finding]
  1000   C1305428:Dressing [Daily or Recreational Activity]
   966 E C0453926:Dress [Manufactured Object]

Phrase: ","

Phrase: "or"

Phrase: "personal hygiene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0564673:personal hygiene [Individual Behavior]
   861   C0020405:Hygiene [Biomedical Occupation or Discipline]
   861   C0518462:hygiene [Finding]
Processing 00000000.tx.119: Women are more likely to attend to household chores and are equally likely to deal with money management compared to men (55). 

Phrase: "Women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "are"

Phrase: "more likely to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205172:More [Functional Concept]
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "attend to household chores"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0020052:Household [Family Group]
   770   C1999232:attend [Functional Concept]
   737   C3273800:Chore [Daily or Recreational Activity]

Phrase: "and"

Phrase: "are"

Phrase: "equally likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "deal with money management"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0016116:money management [Occupational Activity]
   770   C0001554:Management [Occupational Activity]
   770   C0376636:management [Health Care Activity]
   770   C0870909:Money [Manufactured Object]
   770   C1273870:Management [Occupational Activity]
   770   C3273539:Management [Occupation or Discipline]

Phrase: "compared to men (55"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0025266:Men [Population Group]
   770   C0450382:55 [Intellectual Product]
   770   C1707455:Compared [Activity]
   737 E C0024554:MAN [Finding]
   737 E C0086418:Man [Human]

Phrase: ")."
Processing 00000000.tx.120: Long term care in nursing facilities may be necessary in the later stages of AD. 

Phrase: "Long term care in nursing facilities"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   864   C1517936:Long-Term Care Nursing [Biomedical Occupation or Discipline]
   847   C1708733:Long-Term Care Facility [Health Care Related Organization]
   833   C0023977:long-term care [Health Care Activity]
   833   C1547194:Long Term Care [Health Care Related Organization]
   833   C1552238:Long-Term Care [Professional or Occupational Group]
   790   C0443252:Long-term [Temporal Concept]
   783   C0028678:nursing care [Therapeutic or Preventive Procedure]
   783   C0028682:Nursing Care [Health Care Activity]
   783   C1552413:Nursing Care [Health Care Related Organization]
   753   C0205166:Long [Qualitative Concept]
   753   C1515273:Term [Temporal Concept]
   753   C1705313:Term [Idea or Concept]
   753   C1706317:Long [Qualitative Concept]
   753   C1947933:Care [Activity]
   753   C2826302:TERM [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "necessary in the later stages of AD."
Processing 00000000.tx.121: Major determinants of institutionalization include incontinence, behavioral disturbance, strength of the care-giving bond (spouses are most likely to continue home care), as well as underlying social and cultural values. 

Phrase: "Major determinants of institutionalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1521761:Determinant [Functional Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "incontinence,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0021167:Incontinence [Disease or Syndrome]
   928 E C0231238:Incontinent [Functional Concept]

Phrase: "behavioral disturbance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2699787:Disturbance [Qualitative Concept]

Phrase: "strength of the care-giving bond"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0678599:bond strength [Quantitative Concept]
   753   C0237897:Strength [Quantitative Concept]
   753   C0808080:Strength [Idea or Concept]
   753   C1705922:Strength [Qualitative Concept]

Phrase: "(spouses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162409:Spouses [Family Group]

Phrase: "are"

Phrase: "most likely to"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0750501:most likely [Idea or Concept]
   827   C0205393:Most [Quantitative Concept]
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]
   755 E C0033204:Likelihood [Quantitative Concept]

Phrase: "continue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continue [Idea or Concept]

Phrase: "home care"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0204977:Home Care [Health Care Activity]
  1000   C0994454:home care [Health Care Activity]
   861   C0442519:Home [Conceptual Entity]
   861   C1947933:Care [Activity]

Phrase: ")"

Phrase: ","

Phrase: "as well as"

Phrase: "underlying social"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0728831:Social [Functional Concept]

Phrase: "and"

Phrase: "cultural values."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0683623:cultural values [Idea or Concept]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.122: Besides the moral and cultural issues, the cost to society for long term care has led to programs to enhance the home care system, reducing care-giver burden and attempting to forestall spousal and family impoverishment frequently imposed by the tremendous costs of long term care. 

Phrase: "Besides the moral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026531:Moral [Idea or Concept]
  1000   C0026532:moral [Idea or Concept]

Phrase: "and"

Phrase: "cultural issues,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033213:Issue [Finding]
   827   C1706387:Issue [Intellectual Product]

Phrase: "the cost to society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   909   C0683770:cost to society [Quantitative Concept]
           cost society
   770   C0010186:Cost [Quantitative Concept]
   770   C0220812:cost [Quantitative Concept]

Phrase: "for long term care"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0023977:long-term care [Health Care Activity]
  1000   C1547194:Long Term Care [Health Care Related Organization]
  1000   C1552238:Long-Term Care [Professional or Occupational Group]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C1947933:Care [Activity]
   827   C2826302:TERM [Intellectual Product]

Phrase: "has"

Phrase: "led to programs to"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   770   C0376691:Programs [Intellectual Product]
   770   C1708698:LED [Manufactured Object]
   770   C3484370:Programs [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C1709697:Program [Conceptual Entity]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C2728259:Program [Pharmacologic Substance]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the home care system,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]
   734   C0204977:Home Care [Health Care Activity]
   734   C0994454:home care [Health Care Activity]

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "care-giver burden"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C2828008:Burden [Idea or Concept]
   734   C0085537:care giver [Professional or Occupational Group]
   734   C1546494:Care giver [Idea or Concept]

Phrase: "and"

Phrase: "attempting to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1516084:Attempt [Event]

Phrase: "forestall"

Phrase: "spousal"

Phrase: "and"

Phrase: "family impoverishment frequently"

Phrase: "imposed by the tremendous costs of long term care."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0023977:long-term care [Health Care Activity]
   790   C1547194:Long Term Care [Health Care Related Organization]
   790   C1552238:Long-Term Care [Professional or Occupational Group]
   764   C0443252:Long-term [Temporal Concept]
   742   C0010186:Costs [Quantitative Concept]
   742   C0205166:Long [Qualitative Concept]
   742   C0220812:Costs [Quantitative Concept]
   742   C1515273:Term [Temporal Concept]
   742   C1705313:Term [Idea or Concept]
   742   C1706317:Long [Qualitative Concept]
   742   C1947933:Care [Activity]
   742   C2826302:TERM [Intellectual Product]
Processing 00000000.tx.123: Attempts to change this at the level of national health care programs, such as Medicare, have not been instituted to date. 

Phrase: "Attempts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "this at the level of national health care programs,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   784   C0018759:Level of Health [Qualitative Concept]
           Health Level
   784   C0027459:National Health Programs [Health Care Activity]
   784   C1547668:Level of Care [Idea or Concept]
   784   C1548572:Level of care [Intellectual Product]
   781   C0679897:care health programs [Health Care Activity]
   764   C0086388:Health Care [Health Care Activity]
   762   C0681788:national level [Spatial Concept]
   742   C0018684:Health [Idea or Concept]
   742   C0376691:Programs [Intellectual Product]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1080058:This [Eukaryote]
   742   C1547707:Level [Geographic Area]
   742   C1947933:Care [Activity]
   742   C2946261:Level [Pharmacologic Substance]
   742   C3245503:national [Intellectual Product]
   742   C3484370:Programs [Functional Concept]
   708 E C1709697:Program [Conceptual Entity]
   708 E C2728259:Program [Pharmacologic Substance]

Phrase: "such as Medicare,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018717:Medicare [Governmental or Regulatory Activity]
  1000   C1546906:Medicare [Health Care Related Organization]
  1000   C1547152:Medicare [Intellectual Product]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "instituted to date."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0011008:Date [Temporal Concept]
   790   C2348077:Date [Food]
   756   C0021622:institute [Organization]
   756   C1272753:Institute [Idea or Concept]
Processing 00000000.tx.124: Studies focusing on the burdens of care-giving have generally identified that women experience more distress as a result of this role, which may relate to the content of the role as well as the long term stress-coping mechanisms. 

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "focusing on the burdens of care-giving"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0000936:focusing [Clinical Attribute]
   748   C1947933:Care [Activity]
   748   C2981153:Focusing [Finding]
   714 E C0205234:Focus [Spatial Concept]
   714 E C1285542:focus [Functional Concept]
   714   C1947971:Give [Functional Concept]
   714   C2828008:Burden [Idea or Concept]

Phrase: "have"

Phrase: "generally"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "that women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "experience"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237607:experience [Mental Process]
  1000   C0596545:Experience [Mental Process]

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "distress as a result of this role,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0035820:Role [Social Behavior]
   748   C0231303:Distress [Mental Process]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1705810:Role [Conceptual Entity]
   748   C2825142:Result [Finding]

Phrase: "which"

Phrase: "may"

Phrase: "relate to the content of the role"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0035820:Role [Social Behavior]
   748   C0163712:Relate [Organic Chemical]
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]
   748   C1705810:Role [Conceptual Entity]

Phrase: "as well as"

Phrase: "the long term stress-coping mechanisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0441712:Mechanisms [Functional Concept]
   771 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.125: Although the acute effects of care-giving, such as anger, guilt, and depression, are well known and can clearly affect the quality of care, long term health effects of care-giving in AD are less documented (56). 

Phrase: "Although"

Phrase: "the acute effects of care-giving,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "such as anger,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002957:Anger [Mental Process]

Phrase: "guilt,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018379:Guilt [Mental Process]

Phrase: "and"

Phrase: "depression,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0011570:Depression [Mental or Behavioral Dysfunction]
  1000   C0011581:Depression [Mental or Behavioral Dysfunction]
  1000   C0344315:Depression [Finding]
  1000   C0349217:depression nos [Mental or Behavioral Dysfunction]
  1000   C0460137:Depression [Functional Concept]
   928 E C0549249:DEPRESSED [Finding]

Phrase: "are"

Phrase: "well known"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205170:Well [Qualitative Concept]
   861   C0205309:Known [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "can"

Phrase: "clearly"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the quality of care,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C0871200:Quality of Care [Qualitative Concept]
           care quality
   770   C0332306:Quality [Qualitative Concept]

Phrase: "long term health effects of care-giving"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0023983:Long-Term Effects [Phenomenon or Process]
   774   C0086388:Health Care [Health Care Activity]
   748   C0018684:Health [Idea or Concept]
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "in AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "are"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "(56"

Phrase: ")."
Processing 00000000.tx.126: Two endocrine aspects are relevant to care-giving. 

Phrase: "Two endocrine aspects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1547011:Aspect [Quantitative Concept]
   793   C1879746:Aspect [Qualitative Concept]

Phrase: "are"

Phrase: "relevant to care-giving."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1947933:Care [Activity]
   779   C1947971:Give [Functional Concept]
Processing 00000000.tx.127: A voluminous literature exists on biological measures of stress, such as hypothalamic-pituitary-adrenal axis responsivity, but relatively little is known about ways to quantify the actions of care-giving and to correlate with stress markers. 

Phrase: "A voluminous literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023866:Literature [Intellectual Product]
   861   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "exists on biological measures of stress,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   783   C2350026:Biological Stress [Organism Attribute]
   753   C0005532:Biological [Biomedical Occupation or Discipline]
   753   C0038435:Stress [Finding]
   753   C0079809:Measures [Quantitative Concept]
   753   C0205460:biological [Qualitative Concept]
   753   C1879489:Measures [Functional Concept]
   753   C2987476:Exist [Conceptual Entity]
   719 E C0242485:Measure [Functional Concept]

Phrase: "such as hypothalamic-pituitary-adrenal axis responsivity,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C2371924:Responsivity [Mental Process]
   771   C0597719:hypothalamic-pituitary-adrenal axis [Body System]
   733 E C0205342:Responsive [Functional Concept]
   722   C0678897:hypothalamic pituitary axis [Organ or Tissue Function]
   717   C0032022:pituitary adrenal axis [Body System]

Phrase: "but"

Phrase: "relatively little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   861   C0700321:Little [Quantitative Concept]
   861   C2700395:Little [Quantitative Concept]

Phrase: "is"

Phrase: "known about ways to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205309:Known [Qualitative Concept]

Phrase: "quantify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantify [Quantitative Concept]

Phrase: "the actions of care-giving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441472:actions [Functional Concept]
   726 E C3266814:Action [Activity]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "correlate with stress markers."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0038435:Stress [Finding]
   737   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.128: Chronic glucocorticoid exposure from hypothalamic-pituitary-adrenal axis stimulation may damage hippocampal neurons, (28) possibly lending a biological basis to the neuropsychiatric hazards associated with care-giving. 

Phrase: "Chronic glucocorticoid exposure from hypothalamic-pituitary-adrenal axis stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0274281:Exposure, NOS [Injury or Poisoning]
   742   C0332157:Exposure [Clinical Attribute]

Phrase: "may"

Phrase: "damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010957:Damage [Injury or Poisoning]
  1000   C1883709:Damage [Functional Concept]

Phrase: "hippocampal neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(28"

Phrase: ")"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "lending"

Phrase: "a biological basis to the neuropsychiatric hazards"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1527178:Basis [Functional Concept]
   748   C1874451:Basis [Pharmacologic Substance]

Phrase: "associated with care-giving."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C1947933:Care [Activity]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   737   C1947971:Give [Functional Concept]
Processing 00000000.tx.129: The effects of ERT as an adjunct to mood maintenance via interactions with serotoninergic and adrenergic systems suggest that ERT may augment the antidepressant drug response (57). 

Phrase: "The effects of ERT"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   783   C0877035:Estrogen Effects [Finding]
   767   C1518681:Therapy Effect [Finding]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "as an adjunct"

Phrase: "to mood maintenance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024501:Maintenance [Activity]

Phrase: "via interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "with serotoninergic"

Phrase: "and"

Phrase: "adrenergic systems"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   983   C0683206:adrenergic system [Organ or Tissue Function]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that ERT"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0014935:Estrogen Replacement Therapy [Therapeutic or Preventive Procedure]
           Estrogen Replacement
   913   C0279494:estrogen therapy [Therapeutic or Preventive Procedure]
   901   C0086258:Estrogen Replacement [Therapeutic or Preventive Procedure]
   901   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1363945:Therapy [Finding]
   827   C1555302:Replacement [Idea or Concept]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "may"

Phrase: "augment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "the antidepressant drug response"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   901   C0003289:Antidepressant drug [Pharmacologic Substance]
   901   C0683154:drug response [Organism Function]
   827   C0013227:Drug [Pharmacologic Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1254351:Drug [Pharmacologic Substance]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
   771 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   771 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   734 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.130: Summary and conclusion AD is a major public health problem, and demographic trends have led to its being called the epidemic of the century. 

Phrase: "Summary"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "and"

Phrase: "conclusion AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0002395:Alzheimers disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "a major public health problem,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033213:Problem [Finding]

Phrase: "and"

Phrase: "demographic trends"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0681669:demographic trend [Qualitative Concept]
   861   C0040833:trends [Temporal Concept]
   861   C1521798:Trends [Temporal Concept]

Phrase: "have"

Phrase: "led to its"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   790   C1708698:LED [Manufactured Object]
   756 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   756 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   756 E C1522538:Lead [Functional Concept]
   756 E C2348269:Lead [Element, Ion, or Isotope]
   756 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "being"

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "the epidemic of the century."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0014499:Epidemic [Phenomenon or Process]
Processing 00000000.tx.131: Because of increased longevity and the special challenges of ERT, women are well placed to both be at risk for and the beneficiaries of advances in AD therapy. 

Phrase: "Because of increased longevity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023980:Longevity [Temporal Concept]

Phrase: "and"

Phrase: "the special challenges of ERT,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0805586:challenges [Health Care Activity]
   714 E C0798503:Challenge [Clinical Attribute]
   714 E C3274764:Challenge [Conceptual Entity]

Phrase: "women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "are"

Phrase: "well placed to both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205170:Well [Qualitative Concept]
   770   C3146287:Well [Manufactured Object]

Phrase: "be"

Phrase: "at risk for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C1444641:At risk [Qualitative Concept]
   790   C0035647:Risk [Qualitative Concept]
   790   C1516077:At [Spatial Concept]

Phrase: "and"

Phrase: "the beneficiaries of advances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1550502:beneficiary [Idea or Concept]

Phrase: "in AD therapy."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C1363945:Therapy [Finding]
   734   C0002395:Alzheimers disease [Disease or Syndrome]
Processing 00000000.tx.132: Overall increases in health consciousness may impact future AD risk, and it is encouraging that women frequently outnumber men in clinical trials of new therapeutic agents in AD. 

Phrase: "Overall increases in health consciousness"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:increases [Functional Concept]

Phrase: "may"

Phrase: "impact future AD risk,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1281905:disease risk [Finding]
   804   C0035647:Risk [Qualitative Concept]

Phrase: "and"

Phrase: "it"

Phrase: "is"

Phrase: "encouraging"

Phrase: "that women frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043210:Women [Population Group]

Phrase: "outnumber"

Phrase: "men in clinical trials of new therapeutic agents"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0025266:Men [Population Group]
   711 E C0024554:MAN [Finding]
   711 E C0086418:Man [Human]

Phrase: "in AD."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.133: The risk of AD from environmental exposures in the overall life experiences of women is unclear. 

Phrase: "The risk of AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "from environmental exposures"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0014412:Exposures, Environmental [Injury or Poisoning]
   861   C0274281:exposures [Injury or Poisoning]
   861   C0728853:exposures [Phenomenon or Process]
   827 E C0332157:Exposure [Clinical Attribute]

Phrase: "in the overall life"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0376558:Life [Idea or Concept]
   777 E C0595998:lives [Finding]

Phrase: "experiences of women"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043210:Women [Population Group]
   790   C0237607:experience [Mental Process]
   790   C0596545:Experience [Mental Process]

Phrase: "is"

Phrase: "unclear."
Processing 00000000.tx.134: To the extent that education and work promote the development of brain areas such as the association cortex that are preferentially affected in AD, creating a neuronal reserve, advances in womens overall place in society may further help protect them from the ravages of AD. 

Phrase: "To the extent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439792:Extent [Spatial Concept]

Phrase: "that education"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0013621:Education [Educational Activity]
  1000   C0013622:education [Classification]
  1000   C0013658:Education, NOS [Finding]
  1000   C0039401:Education [Educational Activity]
   928 E C1555905:Educational [Intellectual Product]

Phrase: "and"

Phrase: "work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the development of brain areas"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1160340:brain development [Organ or Tissue Function]
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "such as the association cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0596129:association cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "that"

Phrase: "are"

Phrase: "preferentially"

Phrase: "affected in AD,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   737 E C0001721:Affect [Mental Process]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "creating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1706214:Create [Activity]
   966   C3244320:create [Functional Concept]

Phrase: "a neuronal reserve,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347957:Reserve [Activity]

Phrase: "advances in womens overall"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0282416:Overall [Intellectual Product]
   770   C0725066:Advance [Medical Device]
   770   C1561607:Overall [Qualitative Concept]

Phrase: "place in society"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0037455:society [Organization]
   790   C0442504:Place [Spatial Concept]
   790   C1704765:Place [Functional Concept]
   790   C1882509:Place [Activity]
   790   C3496241:place [Disease or Syndrome]

Phrase: "may"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "protect"

Phrase: "them from the"

Phrase: "ravages of AD."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.135: Footnotes 1 Supported by a grant from the National Institutes of Health P50-AG08012. 

Phrase: "Footnotes 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2825232:Footnote [Intellectual Product]

Phrase: "Supported by a grant"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0018173:Grant [Quantitative Concept]
   770   C1521721:Supported [Conceptual Entity]
   770   C1548284:Grant [Idea or Concept]
   737 E C0183683:Support [Medical Device]

Phrase: "from the National Institutes of Health P50-AG08012."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027468:National Institutes of Health [Health Care Related Organization]
Processing 00000000.tx.136: Received December 4, 1998. 

Phrase: "Received December 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "1998."
Processing 00000000.tx.137: Revised February 23, 1999. 

Phrase: "Revised February 23,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450348:23 [Quantitative Concept]
   827   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "1999."
Processing 00000000.tx.138: Accepted February 23, 1999. 

Phrase: "Accepted February 23,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0450348:23 [Quantitative Concept]
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "1999."
Processing 00000000.tx.139: References Maurer K, Volk S, Gerbaldo H, Auguste D. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Maurer K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Volk S,"

Phrase: "Gerbaldo H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Auguste D."
Processing 00000000.tx.140: 1997 Alzheimers disease. 

Phrase: "1997 Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0002395:Alzheimers disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.141: Lancet. 

Phrase: "Lancet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]
Processing 00000000.tx.142: 349:15461549.[CrossRef][Medline] Enserink M. 

Phrase: "349"

Phrase: ":"

Phrase: "15461549."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Enserink M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.143: 1998 First Alzheimers diagnosis confirmed. 

Phrase: "1998 First Alzheimers diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0011900:Diagnosis [Finding]
   812   C1704338:diagnosis [Qualitative Concept]
   812   C1704656:DIAGNOSIS [Research Activity]

Phrase: "confirmed."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.144: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.145: 279:2037.[Free FullText] Blessed G, Tomlinson BE, Roth M. 

Phrase: "279"

Phrase: ":"

Phrase: "2037."

Phrase: "[Free FullText"

Phrase: "] Blessed G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Tomlinson"

Phrase: "BE"

Phrase: ","

Phrase: "Roth M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.146: 1968 The association between quantitative measures of dementia and of senile change in the grey matter of elderly subjects. 

Phrase: "1968"

Phrase: "The association between quantitative measures of dementia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "and of senile change"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0392079:Senile [Finding]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1515981:And [Idea or Concept]
   770   C1705241:Change [Quantitative Concept]
   715 E C0231337:Old age [Finding]
   715 E C1999167:Old age [Population Group]

Phrase: "in the grey matter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018220:Gray matter [Tissue]
   861   C0556636:gray [Quantitative Concept]
   861   C1269776:Gray [Qualitative Concept]

Phrase: "of elderly subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.147: Br J Psychiatry. 

Phrase: "Br J Psychiatry."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0033872:Psychiatry [Professional or Occupational Group]
   827   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   755 E C0205487:Psychiatric [Functional Concept]
Processing 00000000.tx.148: 114:797811.[Medline] Katzman R. 

Phrase: "114"

Phrase: ":"

Phrase: "797811."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Katzman R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.149: 1976 The prevalence and malignancy of Alzheimers disease: A major killer. 

Phrase: "1976"

Phrase: "The prevalence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033105:Prevalence [Quantitative Concept]
  1000   C0220900:prevalence [Quantitative Concept]

Phrase: "and"

Phrase: "malignancy of Alzheimers disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0442867:Malignant disease [Disease or Syndrome]
   770   C0006826:Malignancy [Neoplastic Process]
   770   C1306459:Malignancy [Finding]

Phrase: ":"

Phrase: "A major killer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1336644:KILLER [Gene or Genome]
   861   C1705132:KILLER [Gene or Genome]
Processing 00000000.tx.150: Arch Neurol. 

Phrase: "Arch Neurol."
Processing 00000000.tx.151: 33:217218.[CrossRef][Medline] Evans DA, Funkenstein HH, Albert MS, et al. 

Phrase: "33"

Phrase: ":"

Phrase: "217218."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Evans DA,"

Phrase: "Funkenstein HH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0062941:HH [Organic Chemical,Pharmacologic Substance]
   861   C1384665:HH [Gene or Genome]
   861   C1414862:Hh [Gene or Genome]

Phrase: "Albert MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "et al."
Processing 00000000.tx.152: 1989 Prevalence of Alzheimers disease in a community population of older persons: higher than previously reported. 

Phrase: "1989 Prevalence of Alzheimers disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033105:Prevalence [Quantitative Concept]
   760   C0220900:prevalence [Quantitative Concept]

Phrase: "in a community population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "of older persons"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027361:Persons [Population Group]
   827 E C2347489:Person [Group]
   777 E C1519021:Personal [Organism Attribute]

Phrase: ":"

Phrase: "higher than previously"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.153: JAMA. 

Phrase: "JAMA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422839:JAMA [Gene or Genome]
Processing 00000000.tx.154: 262:25512556.[Abstract] Jorm AF, Jolley D. 

Phrase: "262"

Phrase: ":"

Phrase: "25512556."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Jorm AF,"

Phrase: "Jolley D."
Processing 00000000.tx.155: 1998 The incidence of dementia: a meta-analysis. 

Phrase: "1998"

Phrase: "The incidence of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021149:Incidence [Quantitative Concept]
   770   C0220856:incidence [Functional Concept]

Phrase: ":"

Phrase: "a meta-analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.156: Neurology. 

Phrase: "Neurology."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]
Processing 00000000.tx.157: 51:728733.[Abstract] Drachman DA. 

Phrase: "51"

Phrase: ":"

Phrase: "728733."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Drachman DA."
Processing 00000000.tx.158: 1994 If we live long enough, will we all be demented? 

Phrase: "1994"

Phrase: "If"

Phrase: "we"

Phrase: "live"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1548795:Live [Qualitative Concept]
  1000   C1634625:% live [Qualitative Concept]
  1000   C2982691:Live [Activity]

Phrase: "long enough,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205166:Long [Qualitative Concept]
   861   C1706317:Long [Qualitative Concept]

Phrase: "will"

Phrase: "we all"

Phrase: "be"

Phrase: "demented?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0860630:demented [Mental or Behavioral Dysfunction]
Processing 00000000.tx.159: Neurology. 

Phrase: "Neurology."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]
Processing 00000000.tx.160: 44:15631565.[Medline] Chandra V, Ganguli M, Pandav R, Johnston J, Belle S, DeKosky ST. 

Phrase: "44"

Phrase: ":"

Phrase: "15631565."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chandra V,"

Phrase: "Ganguli M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Pandav R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Johnston J,"

Phrase: "Belle S,"

Phrase: "DeKosky ST."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]
Processing 00000000.tx.161: 1998 Prevalence of Alzheimers disease and other dementias in rural India: the Indo-US study. 

Phrase: "1998 Prevalence of Alzheimers disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033105:Prevalence [Quantitative Concept]
   760   C0220900:prevalence [Quantitative Concept]

Phrase: "and"

Phrase: "other dementias in rural India"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0497327:Dementias [Mental or Behavioral Dysfunction]
   726 E C0011265:dementia [Mental or Behavioral Dysfunction]

Phrase: ":"

Phrase: "the Indo-"

Phrase: "US"

Phrase: "study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.162: Neurology. 

Phrase: "Neurology."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]
Processing 00000000.tx.163: 51:10001008.[Abstract] Hendrie HC, Osuntokun BO, Hall KS, et al. 

Phrase: "51"

Phrase: ":"

Phrase: "10001008."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hendrie HC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020268:HC [Hormone,Pharmacologic Substance,Steroid]
   861   C1413512:Hc [Gene or Genome]

Phrase: "Osuntokun BO,"

Phrase: "Hall KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.164: 1995 Prevalence of Alzheimers disease and dementia in two communities: Nigerian Africans and African Americans. 

Phrase: "1995 Prevalence of Alzheimers disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033105:Prevalence [Quantitative Concept]
   760   C0220900:prevalence [Quantitative Concept]

Phrase: "and"

Phrase: "dementia in two communities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: ":"

Phrase: "Nigerian Africans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0027567:African [Population Group]

Phrase: "and"

Phrase: "African Americans."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085756:African Americans [Population Group]
   861   C0027567:African [Population Group]
   861   C0596070:americans [Population Group]
Processing 00000000.tx.165: Am J Psychiatry. 

Phrase: "Am"

Phrase: "J Psychiatry."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0033872:Psychiatry [Professional or Occupational Group]
   861   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   789 E C0205487:Psychiatric [Functional Concept]
Processing 00000000.tx.166: 152:14851492.[Abstract] Abbott RD, White LR, Ross GW, et al. 

Phrase: "152"

Phrase: ":"

Phrase: "14851492."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Abbott RD,"

Phrase: "White LR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023617:LR [Geographic Area]
   861   C2986899:LR [Idea or Concept]

Phrase: "Ross GW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018387:GW [Geographic Area]

Phrase: "et al."
Processing 00000000.tx.167: 1998 Height as a marker of childhood development and late-life cognitive function: the Honolulu-Asia Aging Study. 

Phrase: "1998 Height as a marker of childhood development"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0489786:Height [Organism Attribute]

Phrase: "and"

Phrase: "late-life cognitive function"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0392335:cognitive function [Mental Process]
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1516691:Cognitive [Functional Concept]
   812   C1705273:Function [Intellectual Product]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]

Phrase: ":"

Phrase: "the Honolulu-Asia Aging Study."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0001811:Ageing [Organism Function]
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]
   779 E C0001779:Age [Organism Attribute]
Processing 00000000.tx.168: Pediatrics. 

Phrase: "Pediatrics."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030755:Paediatrics [Biomedical Occupation or Discipline]
Processing 00000000.tx.169: 102:602609.[Abstract/Free FullText] Friedland RP, Bowirrat A, Treves T, Chapman J, Korczyn AD. 

Phrase: "102"

Phrase: ":"

Phrase: "602609."

Phrase: "[Abstract/Free FullText"

Phrase: "] Friedland RP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1538326:RP [Gene or Genome]
   861   C3541325:RP [Idea or Concept]

Phrase: "Bowirrat A,"

Phrase: "Treves T,"

Phrase: "Chapman J,"

Phrase: "Korczyn AD."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0002395:Alzheimers disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.170: 1998 Alzheimers disease prevalence is high in Israeli Arabs. 

Phrase: "1998 Alzheimers disease prevalence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033105:Prevalence [Quantitative Concept]
   812   C0220900:prevalence [Quantitative Concept]

Phrase: "is"

Phrase: "high in Israeli Arabs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205250:High [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.171: Neurobiol Aging. 

Phrase: "Neurobiol Aging."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001811:Ageing [Organism Function]
Processing 00000000.tx.172: 19:S139. 

Phrase: "19"

Phrase: ":"

Phrase: "S139."
Processing 00000000.tx.173: Sayi JG, Patel NB, Premkumar DR, et al. 

Phrase: "Sayi JG,"

Phrase: "Patel NB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0919442:NB [Gene or Genome]
   861   C1705347:NB [Gene or Genome]

Phrase: "Premkumar DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "et al."
Processing 00000000.tx.174: 1997 Apolipoprotein E polymorphism in elderly east Africans. 

Phrase: "1997 Apolipoprotein E polymorphism in elderly east Africans."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0032529:Polymorphism [Genetic Function]
   744   C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.175: East Afr Med J. 

Phrase: "East Afr Med J."
Processing 00000000.tx.176: 74:668670.[Medline] Caramelli P, Herera E, Nitrini R. 

Phrase: "74"

Phrase: ":"

Phrase: "668670."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Caramelli P,"

Phrase: "Herera E,"

Phrase: "Nitrini R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.177: 1998 The impact of illiteracy on the prevalence of dementia in a Brazilian cohort. 

Phrase: "1998"

Phrase: "The impact of illiteracy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1825598:IMPACT [Gene or Genome]

Phrase: "on the prevalence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033105:Prevalence [Quantitative Concept]
  1000   C0220900:prevalence [Quantitative Concept]

Phrase: "of dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "in a Brazilian cohort."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599755:Cohort [Population Group]
Processing 00000000.tx.178: Neruobiol Aging. 

Phrase: "Neruobiol Aging."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001811:Ageing [Organism Function]
Processing 00000000.tx.179: 19:S28. 

Phrase: "19"

Phrase: ":"

Phrase: "S28."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419731:S28 [Gene or Genome]
Processing 00000000.tx.180: Corder EH, Saunders AM, Strittmatter WJ, et al. 

Phrase: "Corder EH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520135:EH [Geographic Area]

Phrase: "Saunders"

Phrase: "AM"

Phrase: ","

Phrase: "Strittmatter WJ,"

Phrase: "et al."
Processing 00000000.tx.181: 1993 Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimers disease in late onset families. 

Phrase: "1993 Gene dose of apolipoprotein E type 4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0178602:Dose [Quantitative Concept]
   742   C0869039:Dose [Quantitative Concept]
   742   C1114758:Dose # [Clinical Attribute]

Phrase: "and"

Phrase: "the risk of Alzheimers disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "in late onset families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.182: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.183: 261:921923.[Medline] Strittmatter WJ, Saunders AM, Schmechel D, et al. 

Phrase: "261"

Phrase: ":"

Phrase: "921923."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Strittmatter WJ,"

Phrase: "Saunders"

Phrase: "AM"

Phrase: ","

Phrase: "Schmechel D,"

Phrase: "et al."
Processing 00000000.tx.184: 1993 Apolipoprotein E: high avidity binding to -amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. 

Phrase: "1993 Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "high avidity binding to -amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "increased frequency of type 4 allele"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0017270:Allele Frequency [Quantitative Concept]
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "in late-onset familial Alzheimer disease."
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
  1000   C0338448:Late onset familial Alzheimer disease [Disease or Syndrome]
   924   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   884   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   853   C0277558:Familial disease [Disease or Syndrome]
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   817 E C0344339:family disease [Finding]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0015576:familial [Family Group]
   804   C0241888:Familial [Functional Concept]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
   733 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.185: Proc Natl Acad Sci USA. 

Phrase: "Proc Natl Acad Sci USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0041703:USA [Geographic Area]
Processing 00000000.tx.186: 90:19771981.[Abstract] Farrer LA, Cupples LA, Haines JL, et al. 

Phrase: "90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ":"

Phrase: "19771981."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Farrer LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Cupples LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Haines JL,"

Phrase: "et al."
Processing 00000000.tx.187: 1997 Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. 

Phrase: "1997 Effects of age,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "sex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "and"

Phrase: "ethnicity on the association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015031:Ethnicity [Population Group]
   770   C0243103:ethnicity [Qualitative Concept]

Phrase: "between apolipoprotein E genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.188: JAMA. 

Phrase: "JAMA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422839:JAMA [Gene or Genome]
Processing 00000000.tx.189: 278:13491356.[Abstract] Payami H, Montee KR, Kaye JA, et al. 

Phrase: "278"

Phrase: ":"

Phrase: "13491356."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Payami H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Montee KR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022773:KR [Geographic Area]

Phrase: "Kaye JA,"

Phrase: "et al."
Processing 00000000.tx.190: 1994 Alzheimers disease, apolipoprotein E4, and gender. 

Phrase: "1994 Alzheimers disease,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0002395:Alzheimers disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "apolipoprotein E4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "gender."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]
Processing 00000000.tx.191: JAMA. 

Phrase: "JAMA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422839:JAMA [Gene or Genome]
Processing 00000000.tx.192: 271:13161317.[CrossRef][Medline] Duara R, Barker WW, Lopez-Alberola R, et al. 

Phrase: "271"

Phrase: ":"

Phrase: "13161317."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Duara R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Barker WW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1861696:WW [Disease or Syndrome]

Phrase: "Lopez-Alberola R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "et al."
Processing 00000000.tx.193: 1996 Alzheimers disease: interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset. 

Phrase: "1996 Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0002395:Alzheimers disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "interaction of apolipoprotein E genotype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "family history of dementia,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C2315857:Family history of dementia [Finding]
   909   C0455499:History of - dementia [Finding]
   833   C0241889:Family history [Finding]
   833   C1705495:Family History [Idea or Concept]
   783   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   770   C0015576:Family [Family Group]
   770   C0019664:History [Occupation or Discipline]
   770   C0019665:history [Intellectual Product]
   770   C0262512:History, NOS [Organism Attribute]
   770   C0262926:History [Finding]
   770   C1704727:Family [Conceptual Entity]
   770   C1705255:History [Conceptual Entity]
   770   C2004062:History [Finding]

Phrase: "gender,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "education,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0013621:Education [Educational Activity]
  1000   C0013622:education [Classification]
  1000   C0013658:Education, NOS [Finding]
  1000   C0039401:Education [Educational Activity]
   928 E C1555905:Educational [Intellectual Product]

Phrase: "ethnicity,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015031:Ethnicity [Population Group]
  1000   C0243103:ethnicity [Qualitative Concept]
   928 E C0680174:ethnic [Finding]

Phrase: "and"

Phrase: "age of onset."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   790   C0001779:Age [Organism Attribute]
Processing 00000000.tx.194: Neurology. 

Phrase: "Neurology."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]
Processing 00000000.tx.195: 46:15751579.[Abstract] Tang MX, Jacobs D, Stern Y, et al. 

Phrase: "46"

Phrase: ":"

Phrase: "15751579."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Tang MX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025885:MX [Geographic Area]
   861   C0445039:MX [Finding]
   861   C1551087:Mx [Quantitative Concept]

Phrase: "Jacobs D,"

Phrase: "Stern Y,"

Phrase: "et al."
Processing 00000000.tx.196: 1996 Effect of estrogen during menopause on risk and age at onset of Alzheimers disease. 

Phrase: "1996 Effect of estrogen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0877035:Estrogen Effect [Finding]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "during menopause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025320:Menopause [Physiologic Function]
  1000   C0567312:Menopause [Finding]

Phrase: "on risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "and"

Phrase: "age at onset of Alzheimers disease."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   783   C0277793:disease onset [Temporal Concept]
   753   C0001779:Age [Organism Attribute]
   753   C0332162:Onset [Qualitative Concept]
Processing 00000000.tx.197: Lancet. 

Phrase: "Lancet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]
Processing 00000000.tx.198: 348:249252.[CrossRef] Lerner AJ, Koss E, Debanne SM, Rowland DY, Smyth KA, Friedland RP. 

Phrase: "348"

Phrase: ":"

Phrase: "249252."

Phrase: "[CrossRef"

Phrase: "] Lerner AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Koss E,"

Phrase: "Debanne SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Rowland DY,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2826182:DY [Temporal Concept]

Phrase: "Smyth KA,"

Phrase: "Friedland RP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1538326:RP [Gene or Genome]
   861   C3541325:RP [Idea or Concept]
Processing 00000000.tx.199: 1997 Interactions of smoking history with estrogen replacement therapy as protective factors for Alzheimers disease. 

Phrase: "1997 Interactions of smoking history"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "with estrogen replacement therapy"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0014935:Estrogen Replacement Therapy [Therapeutic or Preventive Procedure]
           Estrogen Replacement
   913   C0279494:estrogen therapy [Therapeutic or Preventive Procedure]
   901   C0086258:Estrogen Replacement [Therapeutic or Preventive Procedure]
   901   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1363945:Therapy [Finding]
   827   C1555302:Replacement [Idea or Concept]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "as protective factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0679688:protective factors [Biologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "for Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.200: Lancet. 

Phrase: "Lancet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]
Processing 00000000.tx.201: 349:403404.[Medline] Kawas C, Resnick S, Morrison A, et al. 

Phrase: "349"

Phrase: ":"

Phrase: "403404."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kawas C,"

Phrase: "Resnick S,"

Phrase: "Morrison A,"

Phrase: "et al."
Processing 00000000.tx.202: 1997 A prospective study of estrogen replacement therapy and the risk of developing Alzheimers disease: The Baltimore Longitudinal Study of Aging. 

Phrase: "1997"

Phrase: "A prospective study of estrogen replacement therapy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0033522:prospective study [Research Activity]
   778   C1709709:Prospective Study [Research Activity]
   748   C0023981:prospective [Research Activity]
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "the risk of developing Alzheimers disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1281905:disease risk [Finding]
   753   C0035647:Risk [Qualitative Concept]

Phrase: ":"

Phrase: "The Baltimore Longitudinal Study of Aging."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0023981:Longitudinal Study [Research Activity]
   753   C0205127:Longitudinal [Spatial Concept]
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]
Processing 00000000.tx.203: Neurology. 

Phrase: "Neurology."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]
Processing 00000000.tx.204: 48:15171521.[Abstract] Ripich DN, Petrill SA, Whitehouse PJ, Ziol EW. 

Phrase: "48"

Phrase: ":"

Phrase: "15171521."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ripich DN,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1333964:DN [Disease or Syndrome]
   861   C1707618:DN [Intellectual Product]

Phrase: "Petrill SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Whitehouse PJ,"

Phrase: "Ziol EW."
Processing 00000000.tx.205: 1995 Gender differences in language of AD patients: a longitudinal study. 

Phrase: "1995 Gender differences in language of AD patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0036866:gender differences [Organism Attribute]
   708   C1705241:*Difference [Quantitative Concept]
   708   C1705242:Difference [Qualitative Concept]

Phrase: ":"

Phrase: "a longitudinal study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023981:Longitudinal Study [Research Activity]
   861   C0205127:Longitudinal [Spatial Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.206: Neurology. 

Phrase: "Neurology."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]
Processing 00000000.tx.207: 45:299302.[Abstract] Henderson VW, Buckwalter JG. 

Phrase: "45"

Phrase: ":"

Phrase: "299302."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Henderson VW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2737230:Vw [Immunologic Factor]

Phrase: "Buckwalter JG."
Processing 00000000.tx.208: 1994 Cognitive deficits of men and women with Alzheimers disease. 

Phrase: "1994 Cognitive deficits of men"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0679466:Cognitive deficits [Mental or Behavioral Dysfunction]
   760   C2987487:deficits [Qualitative Concept]
   726 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "and"

Phrase: "women with Alzheimers disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043210:Women [Population Group]
Processing 00000000.tx.209: Neurology. 

Phrase: "Neurology."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]
Processing 00000000.tx.210: 44:9096.[Abstract] Buckwalter JG, Sobel E, Dunn ME, Diz MM, Henderson VW. 

Phrase: "44"

Phrase: ":"

Phrase: "9096."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Buckwalter JG,"

Phrase: "Sobel E,"

Phrase: "Dunn"

Phrase: "ME,"

Phrase: "Diz MM,"

Phrase: "Henderson VW."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2737230:Vw [Immunologic Factor]
Processing 00000000.tx.211: 1993 Gender differences on a brief measure of cognitive functioning in Alzheimers disease Arch Neurol. 

Phrase: "1993 Gender differences on a brief measure of cognitive functioning"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036866:gender differences [Organism Attribute]
   706   C1705241:*Difference [Quantitative Concept]
   706   C1705242:Difference [Qualitative Concept]

Phrase: "in Alzheimers disease Arch Neurol."
Processing 00000000.tx.212: 50:757760.[Abstract] Stern RG, Mohs RC, Bierer LM, et al. 

Phrase: "50"

Phrase: ":"

Phrase: "757760."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Stern RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Mohs RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Bierer LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.213: 1992 Deterioration on the Blessed test in Alzheimers disease: longitudinal data and their implications for clinical trials and identification of subtypes. 

Phrase: "1992 Deterioration on the Blessed test"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0868945:Deterioration [Phenomenon or Process]

Phrase: "in Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "longitudinal data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "their implications for clinical trials"

Phrase: "and"

Phrase: "identification of subtypes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]
Processing 00000000.tx.214: Psychiatry Res. 

Phrase: "Psychiatry Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.215: 42:101110.[CrossRef][Medline] Oxenkrug GF, Gurevich D, Siegel B, Dumlao MS, Gershon S. 

Phrase: "42"

Phrase: ":"

Phrase: "101110."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Oxenkrug GF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016703:GF [Geographic Area]
   861   C1551081:gf [Quantitative Concept]

Phrase: "Gurevich D,"

Phrase: "Siegel B,"

Phrase: "Dumlao MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Gershon S."
Processing 00000000.tx.216: 1989 Correlation between brain-adrenal axis activation and cognitive impairment in Alzheimers disease: is there a gender effect? 

Phrase: "1989 Correlation between brain-adrenal axis activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "cognitive impairment in Alzheimers disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   760   C0684336:Impairment [Pathologic Function]

Phrase: ":"

Phrase: "is"

Phrase: "there"

Phrase: "a gender effect?"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0079399:Gender [Organism Attribute]
   861   C0804628:Gender [Clinical Attribute]
   861   C1280500:Effect [Qualitative Concept]
   861   C1522384:Gender [Organism Attribute]
   861   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.217: Psychiatry Res. 

Phrase: "Psychiatry Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.218: 29:169175.[CrossRef][Medline] Small GW, Kuhl DE, Riege, et al. 

Phrase: "29"

Phrase: ":"

Phrase: "169175."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Small GW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018387:GW [Geographic Area]

Phrase: "Kuhl DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Riege,"

Phrase: "et al."
Processing 00000000.tx.219: 1989 Cerebral Glucose metabolic patterns in Alzheimers disease: effect of gender and age at dementia onset. 

Phrase: "1989 Cerebral Glucose metabolic patterns in Alzheimers disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449774:Patterns [Spatial Concept]

Phrase: ":"

Phrase: "effect of gender"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "age at dementia onset."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0206132:Onset Age [Quantitative Concept]
   770   C0001779:Age [Organism Attribute]
Processing 00000000.tx.220: Arch Gen Psychiatry. 

Phrase: "Arch Gen Psychiatry."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0033872:Psychiatry [Professional or Occupational Group]
   827   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   755 E C0205487:Psychiatric [Functional Concept]
Processing 00000000.tx.221: 46:527532.[Abstract] Sapolsky RM. 

Phrase: "46"

Phrase: ":"

Phrase: "527532."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sapolsky RM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]
Processing 00000000.tx.222: 1992 Stress, the aging brain, and the mechanisms of cell death. 

Phrase: "1992 Stress,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "the aging brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the mechanisms of cell death."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   915   C1708951:Mechanism of Cell Death [Cell Function]
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.223: Cambridge: MIT Press. 

Phrase: "Cambridge"

Phrase: ":"

Phrase: "MIT Press."
Processing 00000000.tx.224: Snowdon DA, Kemper SJ, Mortimer JA, Greiner LH, Wekstein DR, Markesbery WR. 

Phrase: "Snowdon DA,"

Phrase: "Kemper SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Mortimer JA,"

Phrase: "Greiner LH,"

Phrase: "Wekstein DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Markesbery WR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1420193:WR [Gene or Genome]
   861   C1425679:WR [Gene or Genome]
   861   C1862190:WR [Immunologic Factor]
   861   C3538902:WR [Gene or Genome]
Processing 00000000.tx.225: 1996 Linguistic ability in early life and cognitive function and Alzheimers disease in late life. 

Phrase: "1996 Linguistic ability in early life"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "and"

Phrase: "cognitive function"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0392335:cognitive function [Mental Process]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1516691:Cognitive [Functional Concept]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "Alzheimers disease in late life."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   806   C0002395:Alzheimers disease [Disease or Syndrome]
   760   C0012634:Disease [Disease or Syndrome]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.226: JAMA. 

Phrase: "JAMA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422839:JAMA [Gene or Genome]
Processing 00000000.tx.227: 275:528532.[Abstract] Ott BR, Tate CA, Gordon NM, Heindel WC. 

Phrase: "275"

Phrase: ":"

Phrase: "528532."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ott BR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704648:Br. [Conceptual Entity]

Phrase: "Tate CA,"

Phrase: "Gordon NM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "Heindel WC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]
Processing 00000000.tx.228: 1996 Gender differences in the behavioral manifestations of Alzheimers disease. 

Phrase: "1996 Gender differences in the behavioral manifestations of Alzheimers disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036866:gender differences [Organism Attribute]
   706   C1705241:*Difference [Quantitative Concept]
   706   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.229: J Am Geriatr Soc. 

Phrase: "J"

Phrase: "Am"

Phrase: "Geriatr Soc."
Processing 00000000.tx.230: 44:583 587.[Medline] Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. 

Phrase: "44"

Phrase: ":"

Phrase: "583 587."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Snowdon DA,"

Phrase: "Greiner LH,"

Phrase: "Mortimer JA,"

Phrase: "Riley KP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022772:KP [Geographic Area]
   861   C1881334:kp [Quantitative Concept]

Phrase: "Greiner PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Markesbery WR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1420193:WR [Gene or Genome]
   861   C1425679:WR [Gene or Genome]
   861   C1862190:WR [Immunologic Factor]
   861   C3538902:WR [Gene or Genome]
Processing 00000000.tx.231: 1997 Brain infarction and the clinical expression of Alzheimer disease. 

Phrase: "1997 Brain infarction"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0751955:Brain Infarction [Disease or Syndrome]
   827   C0021308:Infarction [Pathologic Function]
   755 E C0333541:Infarcted [Functional Concept]

Phrase: "and"

Phrase: "the clinical expression of Alzheimer disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.232: The Nun study. 

Phrase: "The Nun study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.233: JAMA. 

Phrase: "JAMA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422839:JAMA [Gene or Genome]
Processing 00000000.tx.234: 277:813817.[Abstract] Friedland RP, Farrer LA, Cupples LA, Debanne SM, Lerner AJ, MIRAGE study group. 

Phrase: "277"

Phrase: ":"

Phrase: "813817."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Friedland RP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1538326:RP [Gene or Genome]
   861   C3541325:RP [Idea or Concept]

Phrase: "Farrer LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Cupples LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Debanne SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Lerner AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "MIRAGE study group."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0441833:Group [Idea or Concept]
   827   C0557651:Study [Manufactured Object]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   827   C2603343:Study [Research Activity]
Processing 00000000.tx.235: 1998 Smoking and risk of Alzheimers disease. 

Phrase: "1998 Smoking"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037369:Smoking [Individual Behavior]
   861   C0453996:Smoking [Individual Behavior]
   861   C1881674:SMOKING [Phenomenon or Process]

Phrase: "and"

Phrase: "risk of Alzheimers disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1281905:disease risk [Finding]
   770   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.236: Lancet. 

Phrase: "Lancet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]
Processing 00000000.tx.237: 352:819.[CrossRef] Moritz DJ, Fox PJ, Luscombe FA, Kraemer HC. 

Phrase: "352"

Phrase: ":"

Phrase: "819."

Phrase: "[CrossRef"

Phrase: "] Moritz DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Fox PJ,"

Phrase: "Luscombe FA,"

Phrase: "Kraemer HC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020268:HC [Hormone,Pharmacologic Substance,Steroid]
   861   C1413512:Hc [Gene or Genome]
Processing 00000000.tx.238: 1997 Neurological and psychiatric predictors of mortality in patients with Alzheimer disease in California. 

Phrase: "1997 Neurological"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205494:Neurological [Qualitative Concept]
   861   C2707261:Neurological [Clinical Attribute]

Phrase: "and"

Phrase: "psychiatric predictors of mortality"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2698872:Predictor [Idea or Concept]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "in California."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006754:California [Geographic Area]
  1000   C3146274:California [Plant]
Processing 00000000.tx.239: Arch Neurol. 

Phrase: "Arch Neurol."
Processing 00000000.tx.240: 54:878885.[Abstract] Cummings JL, Masterman DL. 

Phrase: "54"

Phrase: ":"

Phrase: "878885."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Cummings JL,"

Phrase: "Masterman DL."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]
Processing 00000000.tx.241: 1998 Assessment of treatment-associated changes in behavior and cholinergic therapy of neuropsychiatric symptoms in Alzheimers disease. 

Phrase: "1998 Assessment of treatment-associated changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1261322:Assessment [Health Care Activity]
   753   C1516048:Assessment [Activity]

Phrase: "in behavior"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0004927:Behavior [Individual Behavior]
  1000   C2707008:Behavior [Clinical Attribute]
   928 E C2986890:Behavioral [Idea or Concept]

Phrase: "and"

Phrase: "cholinergic therapy of neuropsychiatric symptoms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0039798:therapy [Functional Concept]
   760   C0087111:Therapy [Therapeutic or Preventive Procedure]
   760   C1363945:Therapy [Finding]

Phrase: "in Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.242: J Clin Psychiatry. 

Phrase: "J Clin Psychiatry."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0033872:Psychiatry [Professional or Occupational Group]
   827   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   755 E C0205487:Psychiatric [Functional Concept]
Processing 00000000.tx.243: 59(Suppl 13):2330. 

Phrase: "59"

Phrase: "(Suppl 13"

Phrase: ")"

Phrase: ":"

Phrase: "2330."
Processing 00000000.tx.244: Cummings JL, Back C. 

Phrase: "Cummings JL,"

Phrase: "Back C."
Processing 00000000.tx.245: 1998 The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimers disease. 

Phrase: "1998"

Phrase: "The cholinergic hypothesis of neuropsychiatric symptoms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1512571:Hypothesis [Idea or Concept]

Phrase: "in Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.246: Am J Geriatr Psychiatry. 

Phrase: "Am"

Phrase: "J Geriatr Psychiatry."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0033872:Psychiatry [Professional or Occupational Group]
   827   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   755 E C0205487:Psychiatric [Functional Concept]
Processing 00000000.tx.247: 6:S64S78. 

Phrase: "6"

Phrase: ":"

Phrase: "S64S78."
Processing 00000000.tx.248: Knapp MJ. 

Phrase: "Knapp MJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]
Processing 00000000.tx.249: Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Gracon SI. 

Phrase: "Knopman DS,"

Phrase: "Solomon PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: "Pendlebury WW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1861696:WW [Disease or Syndrome]

Phrase: "Davis CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "Gracon SI."
Processing 00000000.tx.250: 1994 A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimers disease. 

Phrase: "1994"

Phrase: "A 30-week randomized controlled trial of high-dose tacrine"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   782   C0282440:randomized controlled trial [Intellectual Product,Research Activity]
   782   C1096777:Randomized Controlled Trial [Intellectual Product,Research Activity]
   739   C0008976:Trial [Research Activity]
   739   C0034656:randomized [Research Activity]
   739   C2587213:Controlled [Functional Concept]
   706 E C0243148:control [Qualitative Concept]
   706 E C1550141:Control [Substance]
   706 E C1882979:Control [Conceptual Entity]
   706 E C3274648:Control [Qualitative Concept]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.251: JAMA. 

Phrase: "JAMA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422839:JAMA [Gene or Genome]
Processing 00000000.tx.252: 271:985991.[Abstract] Schneider LS, Farlow MR, Henderson VW, Pogoda JM. 

Phrase: "271"

Phrase: ":"

Phrase: "985991."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Schneider LS,"

Phrase: "Farlow MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Henderson VW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2737230:Vw [Immunologic Factor]

Phrase: "Pogoda JM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]
Processing 00000000.tx.253: 1996 Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimers disease. 

Phrase: "1996 Effects of estrogen replacement therapy"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   783   C0877035:Estrogen Effects [Finding]
   767   C1518681:Therapy Effect [Finding]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to tacrine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039245:Tacrine [Organic Chemical,Pharmacologic Substance]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.254: Neurology. 

Phrase: "Neurology."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]
Processing 00000000.tx.255: 46:15801584.[Abstract] Sherwin BB. 

Phrase: "46"

Phrase: ":"

Phrase: "15801584."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sherwin BB."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]
Processing 00000000.tx.256: 1997 Estrogen effects on cognition in menopausal women. 

Phrase: "1997 Estrogen effects on cognition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0877035:Estrogen Effects [Finding]
   760   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   760   C1280500:effects [Qualitative Concept]
   760   C2936882:Estrogen [Pharmacologic Substance]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "in menopausal women."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043210:Women [Population Group]
Processing 00000000.tx.257: Neurology. 

Phrase: "Neurology."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]
Processing 00000000.tx.258: 48(Suppl 7):S21S26. 

Phrase: "48"

Phrase: "(Suppl 7"

Phrase: ")"

Phrase: ":"

Phrase: "S21S26."
Processing 00000000.tx.259: Sherwin BB, Tulandi T. 

Phrase: "Sherwin BB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "Tulandi T."
Processing 00000000.tx.260: 1996 "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin releasing-hormone agonist in women with leiomyomata uteri. 

Phrase: "1996 ""Add-back"" estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "reverses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "cognitive deficits"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0679466:Cognitive deficits [Mental or Behavioral Dysfunction]
   861   C2987487:deficits [Qualitative Concept]
   827 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "induced by a gonadotropin releasing-hormone agonist"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   853   C1268900:gonadotropin-releasing hormone agonist [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   814   C0023610:Gonadotrophin releasing hormone [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   774   C0815016:hormone releasing [Hormone]
   748   C0018061:Gonadotrophin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0019932:Hormone [Hormone]
   748   C0205263:Induced [Functional Concept]
   748   C1283071:Releasing [Functional Concept]
   748   C2987634:Agonist [Pharmacologic Substance]
   748   C3536870:Gonadotropin [Pharmacologic Substance]
   714 E C0030685:Release [Health Care Activity]
   714 E C0391871:Release [Functional Concept]
   714 E C0439180:% release [Quantitative Concept]
   714 E C0680255:release [Health Care Activity]
   714 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "in women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "with leiomyomata uteri."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C0042133:UTERUS, LEIOMYOMA [Neoplastic Process]
   861   C0042149:Uteri [Body Part, Organ, or Organ Component]
   827 E C1269032:Uterus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.261: J Clin Endocrinol Metab. 

Phrase: "J Clin Endocrinol Metab."
Processing 00000000.tx.262: 81:25452549.[Abstract] Yaffe K, Grady D, Pressman A, Cummings S. 

Phrase: "81"

Phrase: ":"

Phrase: "25452549."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Yaffe K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Grady D,"

Phrase: "Pressman A,"

Phrase: "Cummings S."
Processing 00000000.tx.263: 1998 Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women. 

Phrase: "1998 Serum estrogen levels,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   861   C0857965:serum estrogen [Laboratory Procedure]
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C0441889:Levels [Qualitative Concept]
   812   C2936882:Estrogen [Pharmacologic Substance]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "cognitive performance,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597198:Performance [Individual Behavior]
   861   C1882330:Performance [Activity]

Phrase: "and"

Phrase: "risk of cognitive decline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: "in older community women."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0043210:Women [Population Group]
Processing 00000000.tx.264: J Am Geriatr Soc. 

Phrase: "J"

Phrase: "Am"

Phrase: "Geriatr Soc."
Processing 00000000.tx.265: 46:816821.[Medline] Luine VN, Richards ST, Wu VY, Beck KD. 

Phrase: "46"

Phrase: ":"

Phrase: "816821."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Luine VN,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042658:VN [Geographic Area]
   861   C1336937:VN [Gene or Genome]

Phrase: "Richards ST,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "Wu VY,"

Phrase: "Beck KD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026691:KD [Disease or Syndrome]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]
Processing 00000000.tx.266: 1998 Estradiol enhances learning and memory in a spatial memory task and effects levels of monoaminergic neurotransmitters. 

Phrase: "1998 Estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013621:learning [Educational Activity]
  1000   C0023185:Learning [Mental Process]

Phrase: "and"

Phrase: "memory in a spatial memory task"

Phrase: "and"

Phrase: "effects levels of monoaminergic neurotransmitters."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.267: Horm Behav. 

Phrase: "Horm Behav."
Processing 00000000.tx.268: 34:149162.[CrossRef][Medline] Osterlund MK, Hurd Yl. 

Phrase: "34"

Phrase: ":"

Phrase: "149162."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Osterlund MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Hurd Yl."
Processing 00000000.tx.269: 1998 Acute 17-estradiol treatment down-regulates serotonin 5HT1A receptor mRNA expression in the limbic system of female rats. 

Phrase: "1998 Acute 17-estradiol treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0039798:treatment [Functional Concept]
   804   C0087111:Treatment [Therapeutic or Preventive Procedure]
   804   C1522326:Treatment [Functional Concept]
   804   C1533734:Treatment [Therapeutic or Preventive Procedure]
   804   C1705169:Treatment [Conceptual Entity]
   804   C3538994:TREATMENT [Research Activity]

Phrase: "down-regulates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "serotonin 5HT1A receptor mRNA expression in the limbic system of female rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1515670:mRNA Expression [Genetic Function]
   751   C0597360:receptor expression [Genetic Function]
   736   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.270: Brain Res Mol Brain Res. 

Phrase: "Brain Res Mol Brain Res."
Processing 00000000.tx.271: 55:169172.[CrossRef][Medline] Daniel JM, Fader AJ, Spencer AL, Dohanich GP. 

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ":"

Phrase: "169172."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Daniel JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Fader AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Spencer AL,"

Phrase: "Dohanich GP."
Processing 00000000.tx.272: 1997 Estrogen enhances performance of female rats during acquisition of a radial arm maze. 

Phrase: "1997 Estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "performance of female rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0597198:Performance [Individual Behavior]
   770   C1882330:Performance [Activity]

Phrase: "during acquisition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706701:Acquisition [Activity]

Phrase: "of a radial arm maze."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   827   C0083355:MAZE [Therapeutic or Preventive Procedure]
   827   C0442038:Radial [Conceptual Entity]
   827   C0446516:Arm [Body Location or Region]
   827   C0870866:maze [Manufactured Object]
   827   C0920847:Radial [Conceptual Entity]
   827   C1269078:Arm [Body Part, Organ, or Organ Component]
   827   C1269612:Arm [Body Location or Region]
   771 E C0445456:Brachial [Spatial Concept]
   743 E C0206655:ARMS [Neoplastic Process]
   743 E C2681631:ARMS [Gene or Genome]
Processing 00000000.tx.273: Horm Behav. 

Phrase: "Horm Behav."
Processing 00000000.tx.274: 32:217225.[CrossRef][Medline] Packard MG, Teather LA. 

Phrase: "32"

Phrase: ":"

Phrase: "217225."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Packard MG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "Teather LA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]
Processing 00000000.tx.275: 1997 Posttraining estradiol injections enhance memory in ovariectomized rats: cholinergic blockade and synergism. 

Phrase: "1997 Posttraining estradiol injections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0021485:injections [Therapeutic or Preventive Procedure]
   812   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   812   C1828121:Injections [Functional Concept]
   779 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "memory in ovariectomized rats"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0025260:Memory [Mental Process]
   770   C0700327:memory [Finding]
   770   C1706377:Memory [Manufactured Object]
   715 E C0679055:mnemonic [Mental Process]

Phrase: ":"

Phrase: "cholinergic blockade"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332206:Blockade [Functional Concept]
   861   C0599668:cholinergic [Functional Concept]
   861   C3540676:Blockade [Pharmacologic Substance]

Phrase: "and"

Phrase: "synergism."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0599739:synergism [Molecular Function]
   928 E C2986495:Synergistic [Qualitative Concept]
   900 E C0920877:Synergist [Organ or Tissue Function]
Processing 00000000.tx.276: Neurobiol Learn Mem. 

Phrase: "Neurobiol"

Phrase: "Learn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023185:learn [Mental Process]

Phrase: "Mem."
Processing 00000000.tx.277: 68:172188.[CrossRef][Medline] Packard MG, Teather LA. 

Phrase: "68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ":"

Phrase: "172188."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Packard MG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "Teather LA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]
Processing 00000000.tx.278: 1997 Intra-hippocampal estradiol infusion enhances memory in ovariectomized rats. 

Phrase: "1997 Intra-hippocampal estradiol infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0574032:Infusion [Therapeutic or Preventive Procedure]
   804   C1827465:Infusion [Functional Concept]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "memory in ovariectomized rats."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0025260:Memory [Mental Process]
   770   C0700327:memory [Finding]
   770   C1706377:Memory [Manufactured Object]
   715 E C0679055:mnemonic [Mental Process]
Processing 00000000.tx.279: NeuroReport. 

Phrase: "NeuroReport."
Processing 00000000.tx.280: 8:30093013.[Medline] Cordoba Montoya DA, Carrer HF. 

Phrase: "8"

Phrase: ":"

Phrase: "30093013."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cordoba Montoya DA,"

Phrase: "Carrer HF."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018488:Hf [Element, Ion, or Isotope]
   861   C1538440:HF [Gene or Genome]
   861   C3273279:HF [Gene or Genome]
Processing 00000000.tx.281: 1997 Estrogen facilitates induction of long term potentiation in the hippocampus of awake rats. 

Phrase: "1997 Estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "facilitates"

Phrase: "induction of long term potentiation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "in the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "of awake rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.282: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.283: 778:430438.[CrossRef][Medline] Fader AJ, Hendrichson AW, Dohanich GP. 

Phrase: "778"

Phrase: ":"

Phrase: "430438."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fader AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Hendrichson AW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282379:AW [Geographic Area]
   861   C0332281:AW [Qualitative Concept]

Phrase: "Dohanich GP."
Processing 00000000.tx.284: 1998 Estrogen improves performance of reinforced T-maze alternation and prevents the amnestic effects of scopolamine administered systemically or intrahippocampally. 

Phrase: "1998 Estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "improves"

Phrase: "performance of reinforced T-maze alternation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0597198:Performance [Individual Behavior]
   753   C1882330:Performance [Activity]

Phrase: "and"

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the amnestic effects of scopolamine"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "administered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521801:Administered [Functional Concept]
   966 E C1621583:Administer [Functional Concept]

Phrase: "systemically"

Phrase: "or"

Phrase: "intrahippocampally."
Processing 00000000.tx.285: Neurobiol Learn Mem. 

Phrase: "Neurobiol"

Phrase: "Learn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023185:learn [Mental Process]

Phrase: "Mem."
Processing 00000000.tx.286: 69:225240.[CrossRef][Medline] Gibbs RB, Burke AM, Johnson DA. 

Phrase: "69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ":"

Phrase: "225240."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gibbs RB,"

Phrase: "Burke"

Phrase: "AM"

Phrase: ","

Phrase: "Johnson DA."
Processing 00000000.tx.287: 1998 Estrogen replacement attenuates effects of scopolamine and lorazepam on memory acquisition and retention. 

Phrase: "1998 Estrogen replacement"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0014935:Estrogen Replacement [Therapeutic or Preventive Procedure]
   901   C0086258:Estrogen Replacement [Therapeutic or Preventive Procedure]
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1555302:Replacement [Idea or Concept]

Phrase: "attenuates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "effects of scopolamine"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "lorazepam on memory acquisition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0024002:Lorazepam [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "retention."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035280:Retention [Mental Process]
  1000   C0333117:Retention [Functional Concept]
  1000   C1753315:retention [Cell Function]
Processing 00000000.tx.288: Horm Behav. 

Phrase: "Horm Behav."
Processing 00000000.tx.289: 34:112125.[CrossRef][Medline] Sawada H, Ibi M, Kihara T, Urushitani T, Akaike A, Shimohama S. 

Phrase: "34"

Phrase: ":"

Phrase: "112125."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sawada H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ibi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kihara T,"

Phrase: "Urushitani T,"

Phrase: "Akaike A,"

Phrase: "Shimohama S."
Processing 00000000.tx.290: 1998 Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death. 

Phrase: "1998 Estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "protects"

Phrase: "mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1512035:Dopaminergic Neurons [Cell]
   745   C2754100:neuron death [Cell Function]
   742   C0027882:Neurons [Cell]
Processing 00000000.tx.291: J Neurosci Res. 

Phrase: "J Neurosci Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]
Processing 00000000.tx.292: 54:707719.[CrossRef][Medline] Carlson LE, Sherwin BB. 

Phrase: "54"

Phrase: ":"

Phrase: "707719."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Carlson LE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439090:LE [Idea or Concept]
   861   C1423767:LE [Gene or Genome]

Phrase: "Sherwin BB."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]
Processing 00000000.tx.293: 1998 Steroid hormones, memory and mood in a healthy elderly population. 

Phrase: "1998 Steroid hormones,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0301818:steroid hormones [Hormone,Steroid]
   827   C0019932:Hormones [Hormone]
   827   C0038317:Steroid [Steroid]
   743 E C0458083:Hormonal [Qualitative Concept]

Phrase: "memory"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]

Phrase: "and"

Phrase: "mood in a healthy elderly population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026516:Mood [Mental Process]
   753   C2713234:Mood [Clinical Attribute]
Processing 00000000.tx.294: Psychoneuroendocrinology. 

Phrase: "Psychoneuroendocrinology."
Processing 00000000.tx.295: 23:583603.[CrossRef][Medline] Greendale GA, Reboussin BA, Hogan P et al. 

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ":"

Phrase: "583603."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Greendale GA,"

Phrase: "Reboussin BA,"

Phrase: "Hogan P et al."
Processing 00000000.tx.296: 1998 Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Intervention Trial. 

Phrase: "1998 Symptom relief"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0564405:Relief [Finding]

Phrase: "and"

Phrase: "side effects of postmenopausal hormones"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0001688:side effects [Functional Concept]
   773 E C0879626:Side Effect [Pathologic Function]
   760   C0441987:Side [Spatial Concept]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: ":"

Phrase: "results from the Postmenopausal Estrogen/Progestin Intervention Trial."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]
Processing 00000000.tx.297: Obstet Gynecol. 

Phrase: "Obstet Gynecol."
Processing 00000000.tx.298: 92:982988.[Abstract/Free FullText] Polo-Kantola P, Portin R, Polo O, Helenius H, Irjala K, Erkkola R. 

Phrase: "92"

Phrase: ":"

Phrase: "982988."

Phrase: "[Abstract/Free FullText"

Phrase: "] Polo-Kantola P,"

Phrase: "Portin R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Polo O,"

Phrase: "Helenius H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Irjala K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Erkkola R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.299: 1998 The effect of short-term estrogen replacement therapy on cognition: a randomized, double-blind, cross-over trial in postmenopausal women. 

Phrase: "1998"

Phrase: "The effect of short-term estrogen replacement therapy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0877035:Estrogen Effect [Finding]
   767   C1518681:Therapy Effect [Finding]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on cognition"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009240:Cognition [Mental Process]
   916 E C2981149:Intellect [Mental Process]
   907 E C0233698:Noesis [Mental or Behavioral Dysfunction]

Phrase: ":"

Phrase: "a randomized, double-blind, cross-over trial"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0150097:cross over trial [Research Activity]
           CROSS-OVER
   827   C0010366:cross over [Genetic Function]
   799   C0008976:Trial [Research Activity]
   799   C2828360:Cross [Conceptual Entity]

Phrase: "in postmenopausal women."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0043210:Women [Population Group]
   861   C0232970:postmenopausal [Temporal Concept]
Processing 00000000.tx.300: Obstet Gynecol. 

Phrase: "Obstet Gynecol."
Processing 00000000.tx.301: 91:459466.[Abstract/Free FullText] Resnick SM, Metter EJ, Zonderman AB. 

Phrase: "91"

Phrase: ":"

Phrase: "459466."

Phrase: "[Abstract/Free FullText"

Phrase: "] Resnick SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Metter EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "Zonderman AB."
Processing 00000000.tx.302: 1997 Estrogen replacement therapy and longitudinal decline in visual memory. 

Phrase: "1997 Estrogen replacement therapy"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   923   C0014935:Estrogen Replacement Therapy [Therapeutic or Preventive Procedure]
           Estrogen Replacement
   875   C0279494:estrogen therapy [Therapeutic or Preventive Procedure]
   861   C0086258:Estrogen Replacement [Therapeutic or Preventive Procedure]
   861   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C0035139:Replacement [Therapeutic or Preventive Procedure]
   812   C0039798:therapy [Functional Concept]
   812   C0087111:Therapy [Therapeutic or Preventive Procedure]
   812   C0559956:Replacement [Functional Concept]
   812   C1363945:Therapy [Finding]
   812   C1555302:Replacement [Idea or Concept]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "longitudinal decline in visual memory."
Processing 00000000.tx.303: A possible protective effect? 

Phrase: "A possible protective effect?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.304: Neurology. 

Phrase: "Neurology."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]
Processing 00000000.tx.305: 49:14911497.[Abstract] Schneider LS, Finch CE. 

Phrase: "49"

Phrase: ":"

Phrase: "14911497."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Schneider LS,"

Phrase: "Finch CE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827664:CE [Idea or Concept]
Processing 00000000.tx.306: 1997 Can estrogens prevent neurodegeneration? 

Phrase: "1997"

Phrase: "Can"

Phrase: "estrogens"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   966 E C2936882:Estrogen [Pharmacologic Substance]
   916 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "neurodegeneration?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.307: Drugs Aging. 

Phrase: "Drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "Aging."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]
Processing 00000000.tx.308: 11:8795.[Medline] Miller B, Cafasso L. 

Phrase: "11"

Phrase: ":"

Phrase: "8795."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Miller B,"

Phrase: "Cafasso L."
Processing 00000000.tx.309: 1992 Gender differences in caregiving: fact or artifact? 

Phrase: "1992 Gender differences in caregiving"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0036866:gender differences [Organism Attribute]
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: ":"

Phrase: "fact"

Phrase: "or"

Phrase: "artifact?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085089:Artefact [Human-caused Phenomenon or Process]
  1000   C1879740:ARTIFACT [Phenomenon or Process]
Processing 00000000.tx.310: Gerontologist. 

Phrase: "Gerontologist."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0586872:Gerontologist [Professional or Occupational Group]
Processing 00000000.tx.311: 32:498507.[Abstract] Mace NL, Whitehouse PJ, Smyth KA. 

Phrase: "32"

Phrase: ":"

Phrase: "498507."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mace NL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027778:NL [Geographic Area]
   861   C0560008:nL [Quantitative Concept]

Phrase: "Whitehouse PJ,"

Phrase: "Smyth KA."
Processing 00000000.tx.312: 1993 Management of patients with dementia. 

Phrase: "1993 Management of patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0001554:Management [Occupational Activity]
   770   C0376636:management [Health Care Activity]
   770   C1273870:Management [Occupational Activity]
   770   C3273539:Management [Occupation or Discipline]

Phrase: "with dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.313: In: Whitehouse PJ, ed. 

Phrase: "In"

Phrase: ":"

Phrase: "Whitehouse PJ,"

Phrase: "ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]
Processing 00000000.tx.314: Dementia. 

Phrase: "Dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.315: Philadelphia: Davis; 

Phrase: "Philadelphia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031525:Philadelphia [Geographic Area]

Phrase: ":"

Phrase: "Davis"

Phrase: ";"
Processing 00000000.tx.316: 400416. 

Phrase: "400416."
Processing 00000000.tx.317: Halbreich U. 

Phrase: "Halbreich U."
Processing 00000000.tx.318: 1997 Role of estrogen in postmenopausal depression. 

Phrase: "1997 Role of estrogen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in postmenopausal depression."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0520665:Postmenopausal depression [Mental or Behavioral Dysfunction]
   861   C0011570:Depression [Mental or Behavioral Dysfunction]
   861   C0011581:Depression [Mental or Behavioral Dysfunction]
   861   C0344315:Depression [Finding]
   861   C0349217:depression nos [Mental or Behavioral Dysfunction]
   861   C0460137:Depression [Functional Concept]
   789 E C0549249:DEPRESSED [Finding]
Processing 00000000.tx.319: Neurology. 

Phrase: "Neurology."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]
Processing 00000000.tx.320: 48(Suppl 7):S16S20.

Phrase: "48"

Phrase: "(Suppl 7"

Phrase: ")"

Phrase: ":"

Phrase: "S16S20."

